AACS
acetoacetyl-CoA synthetase
AACS; acetoacetyl-CoA synthetase; ACSF1; acyl CoA synthetase family member 1; FLJ12389; SUR 5; Acetoacetate CoA ligase; ACSF 1; FLJ41251; Homolog of C. elegans supressor of ras 5; Protein sur 5 homolog; SUR5; protein sur-5 homolog; acetoacetate-CoA ligase; acyl-CoA synthetase family member 1; homolog of C. elegans supressor of ras 5 (sur-5); SUR-5;
ACAA1
acetyl-CoA acyltransferase 1
ACAA1; acetyl-CoA acyltransferase 1; acetyl Coenzyme A acyltransferase 1; 3-ketoacyl-CoA thiolase, peroxisomal; peroxisomal 3 oxoacyl Coenzyme A thiolase; beta-ketothiolase; peroxisomal 3-oxoacyl-CoA thiolase; acetyl-Coenzyme A acyltransferase 1; peroxiso;
ACACA
acetyl-CoA carboxylase alpha
ACACA; acetyl-CoA carboxylase alpha; ACAC, ACC, acetyl Coenzyme A carboxylase alpha; acetyl-CoA carboxylase 1; ACC1; acetyl CoA carboxylase 1; ACC-alpha; acetyl-Coenzyme A carboxylase alpha; ACC; ACAC; ACCA; ACACAD;
ACACB
acetyl-CoA carboxylase beta
ACACB;acetyl-CoA carboxylase beta;acetyl Coenzyme A carboxylase beta;acetyl-CoA carboxylase 2;ACC2;ACCB;acetyl CoA carboxylase 2;HACC275;ACC-beta;acetyl-Coenzyme A carboxylase beta;
ACAT2
acetyl-CoA acetyltransferase 2
ACAT2; acetyl-CoA acetyltransferase 2; acetyl-CoA acetyltransferase, cytosolic; acetoacetyl Coenzyme A thiolase; cytosolic acetoacetyl-CoA thiolase; acetyl-CoA transferase-like protein;
ACE
angiotensin I converting enzyme
ACE; angiotensin I converting enzyme; DCP; ICH; ACE1; DCP1; CD143; MVCD3; angiotensin-converting enzyme; kininase II; peptidase P; CD143 antigen; testicular ECA; carboxycathepsin; dipeptidyl carboxypeptidase 1; dipeptidyl carboxypeptidase I; angiotensin converting enzyme, somatic isoform; angiotensin I converting enzyme (peptidyl-dipeptidase A) 1; angiotensin I converting enzyme peptidyl-dipeptidase A 1 transcript;
Ache
acetylcholinesterase (Yt blood group)
ACHE; acetylcholinesterase (Yt blood group); YT; ACEE; ARACHE; N-ACHE;
ALPP
ALPP alkaline phosphatase, placental
ALPP; alkaline phosphatase, placental; alkaline phosphatase, placental (Regan isozyme); alkaline phosphatase, placental type; Regan isozyme; PLAP-1; glycerophosphatase; alkaline phosphomonoesterase; placental alkaline phosphatase 1; alkaline phosphatase Regan isozyme; ALP; PALP; PLAP; FLJ61142;
AMACR
alpha-methylacyl-CoA racemase
AMACR; alpha-methylacyl-CoA racemase; RM; RACE; CBAS4; AMACRD; 2-methylacyl-CoA racemase; OTTHUMP00000115916; OTTHUMP00000115917; OTTHUMP00000219978; TTHUMP00000219979; TTHUMP00000219980; EC 5.1.99.4; P504S;
BTC
betacellulin
BTC; betacellulin; probetacellulin; Betacellulin; Betacellulin precursor; BTC; BTC_HUMAN; OTTHUMP00000160600; OTTHUMP00000219057; Probetacellulin; OTTHUMP00000160600; OTTHUMP00000219057;
CAT
Chloramphenicol acetyltransferase
E. coli Chloramphenicol acetyltransferase; E. coli CAT; Escherichia coli Chloramphenicol acetyltransferase; Escherichia coli CAT; CAT;
Cdh3
cadherin 3, type 1, P-cadherin (placental)
CDH3; cadherin 3, type 1, P-cadherin (placental); CDHP; HJMD; PCAD;
CHST15
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15
CHST15; carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15; carbohydrate sulfotransferase 15; B cell RAG associated protein; BRAG; GALNAC4S 6ST; KIAA0598; N acetylgalactosamine 4 sulfate 6 O sulfotransferase; hBRAG; B-cell RAG-associat;
CLIC1
chloride intracellular channel 1
CLIC1; chloride intracellular channel 1; chloride intracellular channel protein 1; NCC27; p64CLCP; hRNCC; RNCC protein; chloride channel ABP; nuclear chloride ion channel 27; nuclear chloride ion channel protein; regulatory nuclear chloride ion channel pr;
CLIC2
chloride intracellular channel 2
CLIC2; chloride intracellular channel 2; chloride intracellular channel protein 2; XAP121; CLIC 2b; CLIC2_HUMAN; CLIC2b; OTTHUMP00000196471; XAP 121; OTTHUMP00000024248;
CLIC3
chloride intracellular channel 3
CLIC3; chloride intracellular channel 3; chloride intracellular channel protein 3;
CLIC4
chloride intracellular channel 4
CLIC4; chloride intracellular channel 4; chloride intracellular channel protein 4; CLIC4L; DKFZP566G223; H1; huH1; p64H1; chloride intracellular channel 4 like; intracellular chloride ion channel protein p64H1; MTCLIC; FLJ38640;
CSH1
chorionic somatomammotropin hormone 1 (placental lactogen)
CSH1; chorionic somatomammotropin hormone 1 (placental lactogen); chorionic somatomammotropin hormone; choriomammotropin; chorionic somatomammotropin A; CSA; CSMT; FLJ75407; hCS A; PL; placental lactogen; CS-1; hCS-A;
DLAT
dihydrolipoamide S-acetyltransferase
DLAT; dihydrolipoamide S-acetyltransferase; DLTA; PDCE2; PDC-E2; dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial; PBC; M2 antigen complex 70 kDa subunit; pyruvate dehydrogenase complex component E2; E2 component of pyruvate dehydrogenase complex; 70 kDa mitochondrial autoantigen of primary biliary cirrhosis; dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex; dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex mitochondrial;
FAS
Fas cell surface death receptor
FAS; Fas cell surface death receptor; APT1; CD95; FAS1; APO-1; FASTM; ALPS1A; TNFRSF6;
FIBP
fibroblast growth factor (acidic) intracellular binding protein
FIBP;fibroblast growth factor (acidic) intracellular binding protein;acidic fibroblast growth factor intracellular-binding protein;FGFIBP;aFGF intracellular-binding protein;FGF-1 intracellular-binding protein;FIBP-1;
GAMT
Gamt guanidinoacetate methyltransferase
GAMT; guanidinoacetate methyltransferase; guanidinoacetate N-methyltransferase; Spintz1; AA571402;
GNPNAT1
glucosamine-phosphate N-acetyltransferase 1
GNPNAT1; glucosamine-phosphate N-acetyltransferase 1; glucosamine 6-phosphate N-acetyltransferase; FLJ10607; Gpnat1; phosphoglucosamine acetylase; phosphoglucosamine transacetylase; GNPNAT;
GNS
glucosamine (N-acetyl)-6-sulfatase
GNS; glucosamine (N-acetyl)-6-sulfatase; N-acetylglucosamine-6-sulfatase; N acetylglucosamine 6 sulfatase; Sanfilippo disease IIID; N28088; 2610016K11Rik; AU042285; C87209; G6S; Glucosamine (N-acetyl) 6 sulfatase; Glucosamine 6 sulfatase; Glucosamine-6-sulfatase; GNS_HUMAN; MGC21274; N acetylglucosamine 6 sulfatase [Precursor];
GOT1
glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1)
GOT1; glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1); aspartate aminotransferase, cytoplasmic; transaminase A; growth-inhibiting protein 18; glutamate oxaloacetate transaminase 1; GIG18; ASTQTL1;
HAT1
histone acetyltransferase 1
HAT1; histone acetyltransferase 1; histone acetyltransferase type B catalytic subunit; KAT1; HAT 1; HAT1_HUMAN; Histidine aminotransferase 1; OTTHUMP00000163124;
HDAC1
histone deacetylase 1
HDAC1; histone deacetylase 1; HD1; RPD3; GON-10; RPD3L1; reduced potassium dependency, yeast homolog-like 1;
HDAC2
histone deacetylase 2
HDAC2; histone deacetylase 2; HD2; RPD3; YAF1; YY1-associated factor 1; transcriptional regulator homolog RPD3;
HDAC4
histone deacetylase 4
HDAC4; histone deacetylase 4; HD4; AHO3; BDMR; HDACA; HA6116; HDAC-4; HDAC-A; histone deacetylase A;
HDAC5
histone deacetylase 5
HDAC5; histone deacetylase 5; FLJ90614; KIAA0600; NY CO 9; antigen NY-CO-9; HD5; NY-CO-9;
HDAC7
histone deacetylase 7
HDAC7; histone deacetylase 7; HD7A; HDAC7A; HD7; histone deacetylase 7A;
HDAC8
histone deacetylase 8
HDAC8; histone deacetylase 8; HD8; WTS; RPD3; CDA07; CDLS5; MRXS6; HDACL1; histone deacetylase-like 1; Wilson-Turner X-linked mental retardation syndrome; Wilson-Turner syndrome (mental retardation, X-linked, syndromic-6, with gynecomastia and obesity);
HDAC9
histone deacetylase 9
HDAC9; histone deacetylase 9; HD7; HDAC; HDAC7B; KIAA0744; MITR; histone deacetylase 7B; histone deacetylase 4/5-related protein; MEF-2 interacting transcription repressor (MITR) protein; HD9; HD7b; HDRP; HDAC7; HDAC9B; HDAC9FL; DKFZp779K1053;
HEXIM1
hexamethylene bis-acetamide inducible 1
HEXIM1; hexamethylene bis-acetamide inducible 1; CLP1; EDG1; HIS1; MAQ1; protein HEXIM1; HMBA-inducible; menage a quatre 1; cardiac lineage protein 1; menage a quatre protein 1; estrogen down-regulated gene 1 protein; hexamthylene bis-acetamide inducible 1; hexamethylene bisacetamide-inducible protein; hexamethylene bis-acetamide-inducible protein 1; hexamethylene-bis-acetamide-inducible transcript 1;
KAT2A
K(lysine) acetyltransferase 2A
KAT2A; K(lysine) acetyltransferase 2A; GCN5 general control of amino acid synthesis 5 like 2 (yeast) , GCN5L2; histone acetyltransferase KAT2A; GCN5; PCAF b; STAF97; hsGCN5; lysine acetyltransferase 2A; histone acetyltransferase GCN5; general control of a;
KAT2B
K(lysine) acetyltransferase 2B
KAT2B; K(lysine) acetyltransferase 2B; p300/CBP associated factor , PCAF; histone acetyltransferase KAT2B; GCN5; GCN5L; P/CAF; histone acetylase PCAF; CREBBP-associated factor; p300/CBP-associated factor; lysine acetyltransferase 2B; histone acetyltransfe;
NAA20
N(alpha)-acetyltransferase 20, NatB catalytic subunit
NAT3; NAT5; dJ1002M8.1; N-alpha-acetyltransferase 20, NatB catalytic subunit; OTTHUMP00000030374; OTTHUMP00000205164; OTTHUMP00000205165; natB complex subunit NAT5; N-acetyltransferase 3 homolog; N-acetyltransferase 5 (GCN5-related, putative); N-terminal acetyltransferase complex ARD1 subunit; N-acetyltransferase 5 (ARD1 homolog, S. cerevisiae); N-terminal acetyltransferase B complex catalytic subunit NAT5; N-terminal acetyltransferase B complex catalytic subunit NAA20; N-acetyltransferase 5, ARD1 subunit (arrest-defective 1, S. cerevisiae, homolog);
NAGA
N-acetylgalactosaminidase, alpha-
NAGA; N-acetylgalactosaminidase, alpha-; alpha-N-acetylgalactosaminidase; D22S674; Alpha galactosidase B; Acetylgalactosaminidase, alpha N (alpha galactosidase B); Alpha N acetylgalactosaminidase; GALB; N acetylgalactosaminidase, alpha; alpha-galactosidase B; Acetylgalactosaminidase, alpha-N- (alpha-galactosidase B);
NAGK
N-acetylglucosamine kinase
NAGK; N-acetylglucosamine kinase; N-acetyl-D-glucosamine kinase; EC 2.7.1.59; GlcNAc kinase; GNK; HSA242910; N acetylglucosamine kinase;
NANP
N-acetylneuraminic acid phosphatase
NANP; N-acetylneuraminic acid phosphatase; C20orf147, chromosome 20 open reading frame 147 , haloacid dehalogenase like hydrolase domain containing 4 , HDHD4; N-acylneuraminate-9-phosphatase; dJ694B14.3; MGC26833; Neu5Ac-9-Pase; haloacid dehalogenase-li;
NANS
N-acetylneuraminic acid synthase
NANS; N-acetylneuraminic acid synthase; sialic acid synthase; SAS; EC 2.5.1.56; EC 2.5.1.57; N acetylneuraminate 9 phosphate synthase; N acetylneuraminate synthase; N acetylneuraminic acid phosphate synthase; N acetylneuraminic acid synthase; OTTHUMP00000;
NAPA
N-Acetylprocainamide
N-Acetylprocainamide; NAPA; acecainide; 4-Acetylamino-N-(2-diethylaminoethyl)benzamide; 4-(acetylamino)-n-(2-(diethylamino)ethyl)-benzamid; 4-(acetylamino)-n-[2-(diethylamino)ethyl]-benzamid; 4'-((2-(diethylamino)ethyl)carbamoyl)-acetanilid; 4'-((2-(diethylamino)ethyl)carbamoyl)acetanilide; acecainide; acekainid; n-acetyloprokainamid; N-ACETYLPROCAINAMIDE; TIMTEC-BB SBB005970; N-ACETYLPROCAINAMIDE, 99+%; 4-(Acetylamino)-N-[2-(diethylamino)ethyl]benzamide; N-((1R,2R,3S,4R)-1-FORMYL-2,3,4,5-TETRAHYDROXY-PENTYL)-ACETAMIDE; N-ACETYL-D-GLUCOSAMINE, IMMOBILIZED ON DIVINYLSULFONE-ACTIVATED AGAROSE 6B; N-ACETYL-D-GLUCOSAMINIDE; N-ACETYLGLUCOSAMINE; D-GLCNAC; ACETYL-D-GLUCOSAMINE, N-; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-(acetylamino)-2-deoxy-d-glucos; 2-(acetylamino)-2-deoxy-D-Glucose; acetylglucosamine; 2-Acetanido-2-deoxy-α-D-glucopyranose; N-Acetamideo-2-deoxy-D-glucose; N-acetyl-D-glucosamine; 2-Acetanido-2-deoxy-α-D-glucopyranose; N-Acetamideo-2-deoxy-D-glucose; D-GlcNAc; N-qcetyl-D-glucosamine; 2-Acetamido-2-deoxy-alpga-D-glucopyranose; N-ACETYL-D-GLUCOSAMINE 80 MESH; N-ACETYL-D-GLUCOSAMINE CELL CULTURETESTE D; N-Acetyl-D-Glucosamine97.5-102.5%; N-Acetylglucosamine,USP28:97,5-102,5%HPLC; NSC 52434; D-Glucose, 2-(acetylamino)-2-deoxy-; N-[(3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide; N-ACETYL-D-GLUCOSAMINE COSMETIC GRADE; N-ACETYL-DELTA-GLUCOSAMINE; 2-ACETAMIDO-2-DESOXY-D-GLUCOPYRANOSE, N-ACETYL-D-GLUCOSAMINE; 2-Acetamido-2-deoxy-D-glucopyranose; N-Acetyl-beta-D-glucosamine; 2-Acetamido-2-deoxy-D-glucopyranose, N-Acetyl-D-glucosamine; 2-Acetamido-2-deoxy-D-glucoseN-Acetyl-beta-D-glucosamine; N-Acetyl-D-glucosamine, N-[(1R,2R,3S,4R)-1-Formyl-2,3,4,5-tetrahydroxypentyl]acetamide; NSC 524344; N-Acetyl-D-glucosamine, 98+%; 2-Acetamido-2-deoxy-alpha-glucopyranose; N-ACETYL-D-GLUCOSAMINE extrapure AR for biochemistry; 2-Acetamido-2-deoxy-D-glucose, D-GlcNAc; 2-Acetamido-2-deoxyglucose; 2-Acetamido-D-glucose; D-N-Acetylglucosamine; 2-Acetamido-2-deoxy-D-glucopyranose,98%; N-Acetyl-D-glucosamine; ACETYL-DL-GLUCOSAMINE, N-(P); N-Acetyl-D-glucosamine,2-Acetamido-2-deoxy-D-glucose, D-GlcNAc; N-Acetyl-D-glucosami; 2-AcetaMido-2-deoxy-D-glucopyranose, 98% 10GR; N-Acety-D-GlucosaMine<br/><br/>;
NAT6
N-acetyltransferase 6 (GCN5-related)
NAT6; N-acetyltransferase 6 (GCN5-related); N acetyltransferase 6; N-acetyltransferase 6; FUS2; OTTMUSP00000046404; OTTMUSP00000046405; OTTMUSP00000046406; AI225910; FUS 2; OTTMUSP00000046403; Protein fus 2; Protein fusion 2; protein fusion-2; OTTHUMP00000211057; OTTHUMP00000211058; OTTHUMP00000211060; OTTHUMP00000211061; OTTHUMP00000211062; OTTHUMP00000211063; FUS-2;
NPL
N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase)
NPL; N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase); C1orf13, chromosome 1 open reading frame 13; N-acetylneuraminate lyase; DHDPS1; dihydrodipicolinate synthetase homolog 1 (E. coli); NPL1; NALase; sialic acid aldolase; sialate-pyruva;
PAFAH1B2
platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (30kDa)
PAFAH1B2; platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (30kDa); platelet-activating factor acetylhydrolase IB subunit beta; PAF acetylhydrolase 30 kDa subunit; PAF AH 30 kDa subunit; PAF AH beta subunit; PAF AH subunit beta; PAFAH 30 kDa subunit; PAFAH beta subunit; PAFAH subunit beta; PAFAH1B2 protein; PAFAHB; Platelet activating factor acetylhydrolase IB beta subunit; Platelet activating factor acetylhydrolase IB subunit beta; Platelet activating factor acetylhydrolase isoform Ib beta subunit; PAF-AH subunit beta; PAF-AH 30 kDa subunit; platelet-activating factor acetylhydrolase, isoform Ib, subunit 2 (30kDa); platelet-activating factor acetylhydrolase, isoform Ib, beta subunit 30kDa; platelet-activating factor acetylhydrolase, isoform Ib, beta subunit (30kD);
Pgf
placental growth factor
PGF; placental growth factor; PGFL; PLGF; PlGF-2; D12S1900; SHGC-10760; placenta growth factor; placental growth factor, vascular endothelial growth factor-related protein;
PLA2G7
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
PLA2G7; phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma); platelet-activating factor acetylhydrolase; LDL PLA2; PAFAH; LDL-PLA(2); gVIIA-PLA2; PAF 2-acylhydrolase; PAF acetylhydrolase; group-VIIA phospholipase A2; LDL-associated phospholipase A2; lipoprotein-associated phospholipase A2; 1-alkyl-2-acetylglycerophosphocholine esterase; 2-acetyl-1-alkylglycerophosphocholine esterase; PAFAD; LP-PLA2; LDL-PLA2;
SAT1
spermidine/spermine N1-acetyltransferase 1
SAT1; spermidine/spermine N1-acetyltransferase 1; diamine acetyltransferase 1; DC21; EC 2.3.1.57; KFSD; Polyamine N acetyltransferase 1; Polyamine N-acetyltransferase 1; Putrescine acetyltransferase; SAT; SAT1_HUMAN; Spermidine/spermine N(1) acetyltransferase 1; Spermidine/spermine N(1)-acetyltransferase 1; SSAT 1; SSAT; SSAT-1;
Taar1
trace amine associated receptor 1
TAAR1; trace amine associated receptor 1; trace amine receptor 1 , TRAR1; trace amine-associated receptor 1; TA1; TAR1; taR-1; trace amine receptor 1; TRAR1; RP11-295F4.9; MGC126874; MGC138399;
TNFRSF10C
tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain
TNFRSF10C; CD263; DCR1; DCR1-TNFR; LIT; TRAIL-R3; TRAILR3; TRID; tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain;
MUC1
mucin 1, cell surface associated
MUC1; mucin 1, cell surface associated; EMA; MCD; PEM; PUM; KL-6; MAM6; MCKD; PEMT; CD227; H23AG; MCKD1; MUC-1; ADMCKD; ADMCKD1; CA 15-3; MUC-1/X; MUC1/ZD; MUC-1/SEC; mucin-1; episialin; DF3 antigen; H23 antigen; cancer antigen 15-3; krebs von den Lungen-6; mucin 1, transmembrane; carcinoma-associated mucin; polymorphic epithelial mucin; peanut-reactive urinary mucin; tumor associated epithelial mucin; breast carcinoma-associated antigen DF3; tumor-associated epithelial membrane antigen;
MUC16
mucin 16, cell surface associated
MUC16; mucin 16, cell surface associated; CA125; mucin-16; CA-125; MUC-16; CA125 ovarian cancer antigen; ovarian carcinoma antigen CA125; ovarian cancer-related tumor marker CA125; FLJ14303; Igovomab; Indimacis-125; 171656-50-1; Abagovomab; 792921-10-9;
NAA10
N(alpha)-acetyltransferase 10, NatA catalytic subunit
TE2; ARD1; ARD1A; DXS707; MGC71248; N-alpha-acetyltransferase 10, NatA catalytic subunit; OTTHUMP00000026001; OTTHUMP00000026002; OTTHUMP00000064808; OTTHUMP00000064809; OTTHUMP00000180622; OTTHUMP00000180623; ARD1 homolog, N-acetyltransferase; ARD1 homolog A, N-acetyltransferase; N-acetyltransferase ARD1, human homolog of; N-terminal acetyltransferase complex ARD1 subunit homolog A;
NAT1
N-acetyltransferase 1 (arylamine N-acetyltransferase)
NAT1; N-acetyltransferase 1 (arylamine N-acetyltransferase); AAC1; arylamine N-acetyltransferase 1; ARY1_HUMAN; Arylamide acetylase 1; Arylamine N acetyltransferase 1; MNAT; Monomorphic arylamine N acetyltransferase; Monomorphic arylamine N-acetyltransferase; N acetyltransferase type 1; N-acetyltransferase type 1; NAT 1; NAT-1; NATI; OTTHUMP00000122488; OTTHUMP00000224577; OTTHUMP00000224578; OTTHUMP00000224579;
AADAC
arylacetamide deacetylase (esterase)
AADAC; arylacetamide deacetylase (esterase); arylacetamide deacetylase; CES5A1; DAC; Aada; OTTHUMP00000216826; OTTHUMP00000216827;
ACAA2
acetyl-CoA acyltransferase 2
ACAA2; acetyl-CoA acyltransferase 2; acetyl Coenzyme A acyltransferase 2; 3-ketoacyl-CoA thiolase, mitochondrial; DSAEC; mitochondrial 3 oxoacyl Coenzyme A thiolase; T1; beta ketothiolase; beta-ketothiolase; acetyl-Coenzyme A acyltransferase 2; mitochondr;
ALPPL2
alkaline phosphatase, placental-like 2
ALPPL2; alkaline phosphatase, placental-like 2; alkaline phosphatase, placental-like; ALP-1; Nagao isozyme; germ cell alkaline phosphatase; alkaline phosphatase Nagao isozyme; placental-like alkaline phosphatase; testicular and thymus alkaline phosphatase;
B3GNT2
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2
B3GNT2; UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2; B3GNT1, UDP GlcNAc:betaGal beta 1,3 N acetylglucosaminyltransferase 1; B3GN T1; B3GN T2; B3GNT 2; BETA3GNT; B3GNT; Beta 1 3 galactosyltransferase 7; Beta3Gn T1; beta3Gn-T1; beta3Gn-T2; beta-1,3-Gn-T1; beta-1,3-Gn-T2; beta-1,3-N-acetylglucosaminyltransferase bGnT-1; beta-1,3-N-acetylglucosaminyltransferase bGnT-2; UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1; BGNT2; B3GNT1; BGnT-2; B3GN-T2; B3GNT-2;
B4GALNT1
beta-1,4-N-acetyl-galactosaminyl transferase 1
B4GALNT1; beta-1,4-N-acetyl-galactosaminyl transferase 1; GALGT, UDP Gal:betaGlcNAc beta 1,4 N acetylgalactosaminyltransferase transferase 1 , UDP N acetyl alpha D galactosamine:(N acetylneuraminyl) galactosylglucosylceramide N acetylgalactosaminyltransferase (GalNAc T); beta-1,4 N-acetylgalactosaminyltransferase 1; beta1 4GalNAc T; GD2 synthase; GM2 synthase; (N acetylneuraminyl) galactosylglucosylceramide; Beta 1 4 N acetyl galactosaminyl transferase 1; Beta 1 4 N acetylgalactosaminyltransferase 1; GALGT; GalNAc T; GALNACT; GM2/GD2 synthase; SIAT 2; SIAT2; UDP Gal:betaGlcNAc beta 1 4 N acetylgalactosaminyltransferase transferase 1; UDP N acetyl alpha D galactosamine:(N acetylneuraminyl) galactosylglucosylceramide N acetylgalactosaminyltransferase; GalNAc-T; beta1,4GalNAc-T; beta1-4GalNAc-T; GD2 synthase, GM2 synthase; (N-acetylneuraminyl)-galactosylglucosylceramide; UDP-Gal:betaGlcNAc beta-1,4-N-acetylgalactosaminyltransferase transferase 1; UDP-N-acetyl-alpha-D-galactosamine:(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase (GalNAc-T);
BAZ1B
bromodomain adjacent to zinc finger domain, 1B
BAZ1B; bromodomain adjacent to zinc finger domain, 1B; WBSCR9, WBSCR10; tyrosine-protein kinase BAZ1B; transcription factor WSTF; Williams Beuren syndrome chromosome region 9; Williams Beuren syndrome chromosome region 10; WSTF; hWALp2; williams syndrome;
C1GALT1
core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1
C1GALT1; core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1; C1GALT; core 1 beta3 Gal T; T synthase; B3Gal-T8; core 1 beta3-Gal-T1; core 1 O-glycan T-synth;
CLIC5
chloride intracellular channel 5
CLIC5; chloride intracellular channel 5; chloride intracellular channel protein 5; MST130; MSTP130; FLJ90663;
CMAS
cytidine monophosphate N-acetylneuraminic acid synthetase
CMAS; cytidine monophosphate N-acetylneuraminic acid synthetase; N-acylneuraminate cytidylyltransferase; CMP Neu5Ac synthetase; CMP-NeuNAc synthase; CMP-Neu5Ac synthetase; CMP-NeuNAc synthetase; CMP-N-acetylneuraminic acid synthase; CMP-N-acetylneuraminic;
CTBS
chitobiase, di-N-acetyl-
CTBS; chitobiase, di-N-acetyl-; CTB; di-N-acetylchitobiase; Chitobiase di N acetyl; Di N acetylchitobiase; OTTHUMP00000011570; OTTHUMP00000011569;
EMILIN1
elastin microfibril interfacer 1
EMILIN1; elastin microfibril interfacer 1; EMILIN-1; DKFZp586M121; gp115; Elastin microfibril interface located protein 1; Elastin microfibril interface located protein; Elastin microfibril interface-located protein 1; EMIL1_HUMAN; EMILIN 1; EMILIN; OTTHUMP00000122584; EMI;
GALNT6
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6)
GALNT6; UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6); polypeptide N-acetylgalactosaminyltransferase 6; GALNAC T6; GalNAc transferase 6; GalNAcT6; GALNT 6; Polypeptide GalNAc transferase 6; Polypeptide N acetylgalactosaminyltransferase 6; pp GaNTase 6; Protein UDP acetylgalactosaminyltransferase 6; UDP GalNAc:polypeptide N acetylgalactosaminyltransferase 6; UDP N acetyl alpha D galactosamine:polypeptide N acetylgalactosaminyltransferase 6 (GalNAc T6); UDP N acetyl alpha D galactosamine:polypeptide N acetylgalactosaminyltransferase 6; pp-GaNTase 6; protein-UDP acetylgalactosaminyltransferase 6; UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 6; UDP-N-acetyl-alpha-D-galactosamine:; GALNAC-T6;
GALNTL4
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 4
GALNTL4; UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 4; putative polypeptide N-acetylgalactosaminyltransferase-like protein 4; GALNT15; MGC71806; GalNAc T like protein 4; GalNAc T15; GalNAc transferase 18; GALNT18; N acetylgalactosaminyltransferase 15 UDP N acetyl alpha D galactosamine:polypeptide; N acetylgalactosaminyltransferase like 4; N acetylgalactosaminyltransferase like protein 4 UDP N acetyl alpha D galactosamine:polypeptide; Polypeptide GalNAc transferase like protein 4; pp GaNTase like protein 4; Protein UDP acetylgalactosaminyltransferase like protein 4; Protein UDP acetylgalactosaminyltransferase like protein 4 UDP GalNAc:polypeptide; Putative polypeptide N acetylgalactosaminyltransferase like protein 4; UDP GalNAc:polypeptide N acetylgalactosaminyltransferase like protein 4; GalNAc-transferase 18; galNAc-T-like protein 4; pp-GaNTase-like protein 4; polypeptide GalNAc transferase-like protein 4; protein-UDP acetylgalactosaminyltransferase-like protein 4; UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 4; UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 15; GalNAc-T15;
GOT2
glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2)
GOT2; glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2); aspartate aminotransferase, mitochondrial; KAT4; KATIV; kynurenine aminotransferase IV; mitAAT; ASPATA; FABP pm; Got 2; MGC102129; MGC115763; mitochondrial; AATM_HUMAN; AL022787; Aspartate aminotransferase; Aspartate aminotransferase 2; EC 2.6.1.1; FABP 1; FABP-1; FABPpm; Fatty acid binding protein; Fatty acid-binding protein; FLJ40994; Glutamate oxaloacetate transaminase 2; Glutamate oxaloacetate transaminase 2, mitochondrial; Glutamate oxaloacetate transaminase, mitochondrial; Glutamic oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2); mAspAT; Mitochondrial aspartate aminotransferase; OTTMUSP00000017748; Plasma membrane fatty acid binding protein; Plasma membrane-associated fatty acid-binding protein; Transaminase A;
KAT5
K(lysine) acetyltransferase 5
KAT5; K(lysine) acetyltransferase 5; TIP; ESA1; PLIP; TIP60; cPLA2; HTATIP; ZC2HC5; HTATIP1; histone acetyltransferase KAT5; K-acetyltransferase 5; cPLA2 interacting protein; cPLA(2)-interacting protein; 60 kDa Tat-interactive protein; Tat interacting protein, 60kDa; histone acetyltransferase HTATIP; HIV-1 Tat interactive protein, 60kDa;
KRT23
keratin 23 (histone deacetylase inducible)
KRT23; keratin 23 (histone deacetylase inducible); keratin, type I cytoskeletal 23; CK23; DKFZP434G032; HAIK1; K23; MGC26158; CK-23; keratin-23; cytokeratin 23; cytokeratin-23; histone deacetylase inducible keratin 23; type I intermediate filament cytoker;
LFNG
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase
LFNG; LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase; lunatic fringe (Drosophila) homolog , lunatic fringe homolog (Drosophila); beta-1,3-N-acetylglucosaminyltransferase lunatic fringe; SCDO3; 3-N-acetylglucosaminyltransferase lunatic fringe; Beta-1; Beta-13-N-acetylglucosaminyltransferase lunatic fringe; LFNG_HUMAN; O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase; OTTHUMP00000201070; OTTHUMP00000201071; OTTHUMP00000201072; OTTHUMP00000201073;
MFNG
MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase
MFNG; MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase; manic fringe (Drosophila) homolog , manic fringe homolog (Drosophila); beta-1,3-N-acetylglucosaminyltransferase manic fringe; O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase; OTTHUMP00000197828;
MGAT4A
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A
MGAT4A; mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A; mannosyl (alpha 1,3 ) glycoprotein beta 1,4 N acetylglucosaminyltransferase, isoenzyme A; alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferas;
MUC4
mucin 4, cell surface associated
MUC4; mucin 4, cell surface associated; ASGP; MUC-4; HSA276359; mucin-4; testis mucin; tracheobronchial mucin; ascites sialoglycoprotein; mucin 4, tracheobronchial; pancreatic adenocarcinoma mucin;
MYST1
MYST Histone Acetyltransferase 1
hMOF; KAT8; EC 2.3.1.48; FLJ14040 ; histone acetyltransferase MYST1; hMOF; K(lysine) acetyltransferase 8; MOF; MOZ, YBF2/SAS3, SAS2 and TIP60 protein 1; MYST histone acetyltransferase 1; MYST1; MYST-1; ortholog of Drosophila males absent on the first (MOF); OTTHUMP00000163246; OTTHUMP00000236628; probable histone acetyltransferase MYST1;
NAGLU
N-acetylglucosaminidase, alpha
NAGLU; N-acetylglucosaminidase, alpha; NAG; MPS3B; UFHSD; MPS-IIIB; alpha-N-acetylglucosaminidase; N-acetyl-alpha-glucosaminidase;
NAT2
N-acetyltransferase 2 (arylamine N-acetyltransferase)
NAT2; N-acetyltransferase 2 (arylamine N-acetyltransferase); AAC2; arylamine N-acetyltransferase 2; ARY2_HUMAN; Arylamide acetylase 2 (N-acetyltransferase 2, isoniazid inactivation); Arylamide acetylase 2; HGNC:7646; N-acetyltransferase type 2; NAT-2; PNAT; Polymorphic arylamine N-acetyltransferase; OTTHUMP00000161399; OTTHUMP00000224593;
NDST1
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1
NDST1; N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1; HSST; bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1; NST1; NDST-1; HSNST 1; N-HSST 1; N-heparan sulfate sulfotransferase 1; glucosaminyl N-deacetylase/N-sulfotransferase 1;
NDST3
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3
NDST3; N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3; bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 3; HSST3; Bifunctional heparan sulfate N deacetylase/N sulfotransferase 3; Glucosaminyl N deacetylase/N sulfotransferase 3; hNDST 3; hNDST3; HSST 3; MGC130028; MGC130029; N deacetylase/N sulfotransferase (heparan glucosaminyl) 3; N heparan sulfate sulfotransferase 3; N HSST 3; NDST 3; NDST-3; hNDST-3; N-HSST 3; OTTHUMP00000163902; N-heparan sulfate sulfotransferase 3; GlcNAc N-deacetylase/ N-sulfotransferase 3; glucosaminyl N-deacetylase/N-sulfotransferase 3;
PAFAH1B1
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa)
PAFAH1B1; platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa); MDCR, MDS, Miller Dieker syndrome chromosome region , platelet activating factor acetylhydrolase, isoform Ib, alpha subunit (45kD) , platelet activating factor acetylhydrolase, isoform Ib, alpha subunit 45kDa , platelet activating factor acetylhydrolase, isoform Ib, subunit 1 (45kDa); platelet-activating factor acetylhydrolase IB subunit alpha; LIS1; PAFAH; LIS-1; PAFAH alpha; PAF-AH alpha; PAF-AH 45 kDa subunit; lissencephaly 1 protein; lissencephaly-1 protein; PAF acetylhydrolase 45 kDa subunit; platelet-activating factor acetylhydrolase, isoform Ib, subunit 1 (45kDa); platelet-activating factor acetylhydrolase, isoform Ib, alpha subunit (45kD); MDS; LIS2; MDCR;
PAFAH1B3
platelet-activating factor acetylhydrolase 1b, catalytic subunit 3 (29kDa)
PAFAH1B3; platelet-activating factor acetylhydrolase 1b, catalytic subunit 3 (29kDa); platelet activating factor acetylhydrolase, isoform Ib, gamma subunit (29kD) , platelet activating factor acetylhydrolase, isoform Ib, gamma subunit 29kDa , platelet activating factor acetylhydrolase, isoform Ib, subunit 3 (29kDa); platelet-activating factor acetylhydrolase IB subunit gamma; PAF AH1b alpha 1 subunit; PA1B3_HUMAN; PAF acetylhydrolase 29 kDa subunit; PAF AH 29 kDa subunit; PAF AH subunit gamma; PAF-AH 29 kDa subunit; PAF-AH subunit gamma; PAFAH subunit gamma; PAFAHG; Platelet activating factor acetylhydrolase IB subunit gamma; Platelet activating factor acetylhydrolase isoform Ib gamma subunit (29kD); Platelet activating factor acetylhydrolase isoform Ib gamma subunit 29kDa; Platelet activating factor acetylhydrolase isoform Ib gamma subunit; PAF-AH1b alpha 1 subunit; platelet-activating factor acetylhydrolase, isoform Ib, subunit 3 (29kDa;
POMGNT1
protein O-linked mannose beta1,2-N-acetylglucosaminyltransferase
POMGNT1; protein O-linked mannose beta1,2-N-acetylglucosaminyltransferase; protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1; FLJ20277; MGAT1.2; protein O mannose beta 1; 2 N acetylglucosaminyltransferase; UDP-GlcNAc:alpha-D-mannoside be;
RFNG
RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase
RFNG; RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase; radical fringe (Drosophila) homolog , radical fringe homolog (Drosophila); beta-1,3-N-acetylglucosaminyltransferase radical fringe; radical fringe homolog; O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase;
SLC33A1
solute carrier family 33 (acetyl-CoA transporter), member 1
SLC33A1; solute carrier family 33 (acetyl-CoA transporter), member 1; ACATN, acetyl Coenzyme A transporter , spastic paraplegia 42 (autosomal dominant) , SPG42; acetyl-coenzyme A transporter 1; AT 1; AT1; ACATN; Acetyl CoA transporter; Acetyl Coenzyme A transporter; Acetyl coenzyme A transporter 1; Human Angiotensin II Type 1 Receptor; Solute carrier family 33 (acetyl CoA transporter) member 1; Solute carrier family 33 member 1; spastic paraplegia 42 (autosomal dominant); SPG42; OTTHUMP00000212981; OTTHUMP00000212982; OTTHUMP00000212983; AT-1;
SOD3
superoxide dismutase 3, extracellular
SOD3; superoxide dismutase 3, extracellular; EC-SOD; extracellular superoxide dismutase [Cu-Zn];
SPON1
spondin 1, extracellular matrix protein
SPON1; spondin 1, extracellular matrix protein; f-spondin; VSGP/F-spondin; spondin-1; spondin 1, (f-spondin) extracellular matrix protein; vascular smooth muscle cell growth-promoting factor;
ST8SIA2
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2
ST8SIA2; ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2; sialyltransferase 8 (alpha 2, 8 sialytransferase) B , SIAT8B; alpha-2,8-sialyltransferase 8B; HsT19690; ST8SIA II; STX; SIAT8-B; ST8SiaII; sialyltransferase X; sialyltransferase 8B; si;
TNP1
transition protein 1 (during histone to protamine replacement)
TNP1; transition protein 1 (during histone to protamine replacement); spermatid nuclear transition protein 1; TP-1; STP-1; TP1; Interferon-tau; trophoblast protein-1; Trophoblastin; Antiluteolysin; Trophoblast antiluteolytic protein; OTP; IFNT1; IFNT4; Interferon tau-1; Interferon tau-4;
SLC35A3
solute carrier family 35 (UDP-N-acetylglucosamine (UDP-GlcNAc) transporter), member A3
SLC35A3; solute carrier family 35 (UDP-N-acetylglucosamine (UDP-GlcNAc) transporter), member A3; solute carrier family 35 (UDP N acetylglucosamine (UDP GlcNAc) transporter), member 3; UDP-N-acetylglucosamine transporter; DKFZp781P1297; Golgi UDP-GlcNAc transporter; S35A3_HUMAN; Solute carrier family 35 (UDP N acetylglucosamine (UDP GlcNAc) transporter) member A3; Solute carrier family 35 member A3; solute carrier family 35 (UDP-N-acetylglucosamine (UDP-GlcNAc) transporter), member 3;
SRR
serine racemase
SRR; serine racemase; ILV1; ISO1; D-serine dehydratase; L-serine dehydratase; D-serine ammonia-lyase; L-serine ammonia-lyase;
FAHD2A
fumarylacetoacetate hydrolase domain containing 2A
FAHD2A; fumarylacetoacetate hydrolase domain containing 2A; fumarylacetoacetate hydrolase domain-containing protein 2A; CGI 105; FAH2A_HUMAN; FAHD 2A; Fumarylacetoacetate hydrolase domain containing 1; Fumarylacetoacetate hydrolase domain containing protein 2A; MGC131995; OTTHUMP00000207352; CGI-105;
ILVBL
ilvB (bacterial acetolactate synthase)-like
ILVBL; ilvB (bacterial acetolactate synthase)-like; acetolactate synthase-like protein; 209L8; acetolactate synthase homolog; AHAS; FLJ39061; ILV2H; MGC1269; MGC19535; Acetolactate synthase like protein; IlvB (bacterial acetolactate synthase) like; IlvB like protein; IlvB-like protein; ILVBL_HUMAN;
MGAT5
mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase
MGAT5; mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase; alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A; GNT V; glcNAc-T V; N-acetylglucosaminyl-transferase V; mannoside acetylglucosaminyltransferase 5;
ABO
ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)
ABO; ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase); histo-blood group ABO system transferase; A3GALNT; A3GALT1; ABO glycosyltransferase; histo-blood group A transferase; histo-;
ACAT1
acetyl-CoA acetyltransferase 1
ACAT1; acetyl-CoA acetyltransferase 1; ACAT, acetyl Coenzyme A acetyltransferase 1; acetyl-CoA acetyltransferase, mitochondrial; acetoacetyl Coenzyme A thiolase; THIL; acetoacetyl-CoA thiolase; acetyl-Coenzyme A acetyltransferase 1; mitochondrial acetoac;
ARD1A
NAA10 N(alpha)-acetyltransferase 10, NatA catalytic subunit
TE2; ARD1; ARD1A; DXS707; MGC71248; N-alpha-acetyltransferase 10, NatA catalytic subunit; OTTHUMP00000026001; OTTHUMP00000026002; OTTHUMP00000064808; OTTHUMP00000064809; OTTHUMP00000180622; OTTHUMP00000180623; ARD1 homolog, N-acetyltransferase; ARD1 homolog A, N-acetyltransferase; N-acetyltransferase ARD1, human homolog of; N-terminal acetyltransferase complex ARD1 subunit homolog A;
ASMT
acetylserotonin O-methyltransferase
ASMT;acetylserotonin O-methyltransferase;ASMTY;HIOMT;HIOMTY;hydroxyindole O-methyltransferase;acetylserotonin N-methyltransferase;acetylserotonin methyltransferase (Y chromosome);
B3GNT1
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1
B3GNT1; UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1; B3GNT6, UDP GlcNAc:betaGal beta 1,3 N acetylglucosaminyltransferase 6; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase; B3GN T1; BETA3GNTI; iGAT; iGNT; iGnT; poly-N-acetyllactosamine extension enzyme; i-beta-1,3-N-acetylglucosaminyltransferase; beta-1,3-N-acetylglucosaminyltransferase bGnT-6; UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6; B3GNT6; B3GN-T1;
B3GNT3
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3
B3GNT3; UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3; TMEM3; B3GN T3; B3GNT 3; beta 1; 3 N acetylglucosaminyltransferase bGnT 3; beta3Gn T3; HP10328; putative type II membrane protein; transmembrane protein 3; B3GAL T8; B3GALT8; Beta 1,3 galactosyltransferase 8; Beta 3 Gal T8; Beta3Gal T8; Beta3GalT8; BGnT 3; BGnT3; Core 1 extending beta 1,3 N acetylglucosaminyltransferase; Core1 beta3GlcNAcT; UDP Gal:beta GlcNAc beta 1,3 galactosyltransferase 8; UDP GlcNAc:betaGal beta 1,3 N acetylglucosaminyltransferase 3; beta-3-Gx-T8; beta-1,3-Gn-T3; beta-1,3-GalTase 8; core1-beta3GlcNAcT; beta-1,3-N-acetylglucosaminyltransferase bGnT-3; UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 8; core 1 extending beta-1,3-N-acetylglucosaminyltransferase; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 8; B3GN-T3; B3GNT-3; B3GAL-T8; beta3Gn-T3;
BAZ1A
bromodomain adjacent to zinc finger domain, 1A
BAZ1A; bromodomain adjacent to zinc finger domain, 1A; bromodomain adjacent to zinc finger domain protein 1A; ACF1; hACF1; WALp1; WCRF180; ACF1, drosophila, homolog of; ATP dependent chromatin remodelling protein; ATP utilizing chromatin assembly and remodeling factor 1; ATP-dependent chromatin-remodeling protein; ATP-utilizing chromatin assembly and remodeling factor 1; B930060C03; BAZ1A_HUMAN; BC065123; Bromodomain adjacent to zinc finger domain 1A; cbp146; CHRAC subunit ACF1; DKFZp586E0518; FLJ14383; Gtl5; hWALp1; Williams syndrome transcription factor related chromatin remodeling factor 180; Williams syndrome transcription factor-related chromatin-remodeling factor 180; OTTHUMP00000178813; OTTHUMP00000244406; ATP-dependent chromatin remodeling protein; ATP-utilizing chromatin assembly and remodeling fac;
CHAT
choline O-acetyltransferase
CHAT; choline O-acetyltransferase; CHOACTase; choline acetylase; choline acetyltransferase;
CHST4
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 4
CHST4; carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 4; carbohydrate sulfotransferase 4; HEC GLCNAC 6 ST; LSST; Carbohydrate (N acetylglucosamine 6-O) sulfotransferase 4; Galactose/N acetylglucosamine/N acetylglucosamine 6 O sulfotransferase 3; GlcNAc6ST 2; GST 3; HEC GlcNAc6ST; High endothelial cells N acetylglucosamine 6 O sulfotransferase; L selectin ligand sulfotransferase; N acetylglucosamine 6 O sulfotransferase; GST-3; gn6st-2; glcNAc6ST-2; HEC-GlcNAc6ST; OTTHUMP00000174926; L-selectin ligand sulfotransferase; N-acetylglucosamine 6-O-sulfotransferase 2; high endothelial cells N-acetylglucosamine 6-O-sulfotransferase; galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 3; galactose/N-acetylglucosamine/N-acetylgalactosamine 6-O-sulfotransferase 3; GST3; GlcNAc6ST2; HECGLCNAC6ST;
DAK
dihydroxyacetone kinase 2 homolog (S. cerevisiae)
DAK; dihydroxyacetone kinase 2 homolog (S. cerevisiae); dihydroxyacetone kinase 2 homolog (yeast); bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing); DKFZP586B1621; NET45; ATP dependent dihydroxyacetone kinase; Bifunctional ATP dependent dihydroxyacetone kinase/FAD AMP lyase (cyclizing); DHA kinase; Dha kinase/FMN cyclase; DHAK_HUMAN; Dihydroxyacetone kinase; Dihydroxyacetone kinase 2; FAD AMP lyase (cyclic FMN forming); FAD AMP lyase (cyclizing); FAD-AMP lyase (cyclic FMN forming); FAD-AMP lyase (cyclizing); FMN cyclase; Glycerone kinase; OTTHUMP00000235855; OTTHUMP00000235860; FAD-AMP lyase cyclizing; FAD-AMP lyase cyclic FMN forming; ATP-dependent dihydroxyacetone kinase;
DPAGT1
dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase)
DPAGT1; dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase); DPAGT, DPAGT2; UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase; ALG7; CDG Ij; D11S366; DGPT; GPT; Gnpta; H2afx; AU021132; Dolichyl phosphate (UDP N acetylglucosamine) acetylglucosaminephosphotransferase 1 (GlcNAc 1 P transferase); DPAGT2; G1PT; GlcNAc-1-P transferase; GPT_HUMAN; N-acetylglucosamine-1-phosphate transferase; OTTHUMP00000204052; OTTHUMP00000204055; dolichyl-phosphate alpha-N-acetylglucosaminyltransferase; UDP-GlcNAc:dolichyl-phosphate N-acetylglucosaminephosphotransferase; dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P tra; UAGT; UGAT; CDG1J; DPAGT; CDG-Ij;
EFEMP2
EGF containing fibulin-like extracellular matrix protein 2
EFEMP2; EGF containing fibulin-like extracellular matrix protein 2; MBP1; UPH1; FBLN4; ARCL1B; EGF-containing fibulin-like extracellular matrix protein 2; FIBL-4; fibulin 4; fibulin-4; mutant p53 binding protein 1;
FAH
fumarylacetoacetate hydrolase (fumarylacetoacetase)
FAH; fumarylacetoacetate hydrolase (fumarylacetoacetase); fumarylacetoacetase; FAA; beta-diketonase; FLJ51912;
GALNT1
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 1 (GalNAc-T1)
GALNT1; UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 1 (GalNAc-T1); polypeptide N-acetylgalactosaminyltransferase 1; GalNAc T1; protein UDP acetylgalactosaminyltransferase 1; GalNAc transferase 1; GalNAc-T1; GALNT 1; GALT1_HUMAN; Polypeptide GalNAc transferase 1; Polypeptide N acetylgalactosaminyltransferase 1; Polypeptide N-acetylgalactosaminyltransferase 1 soluble form; pp GaNTase 1; pp-GaNTase 1; Protein-UDP acetylgalactosaminyltransferase 1; UDP GalNAc:polypeptide N acetylgalactosaminyltransferase 1; UDP N acetyl alpha D galactosamine:polypeptide N acetylgalactosaminyltransferase 1 (GalNAc T1); UDP N acetyl alpha D galactosamine:polypeptide N acetylgalactosaminyltransferase 1; UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1;
GALNT13
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 13 (GalNAc-T13)
GALNT13; UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 13 (GalNAc-T13); polypeptide N-acetylgalactosaminyltransferase 13; GalNAc T13; KIAA1918; UDP N acetyl alpha D galactosamine:polypeptide N acetylgalactosaminyltransferase 13; GalNAc transferase 13; N acetylgalactosaminyltransferase 13; Polypeptide GalNAc transferase 13; pp GaNTase 13; Protein UDP acetylgalactosaminyltransferase 13; UDP GalNAc:polypeptide N acetylgalactosaminyltransferase 13; UDP N acetyl alpha D galactosamine:polypeptide; pp-GaNTase 13; protein-UDP acetylgalactosaminyltransferase 13; UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 13; GalNAc-T13; H_NH0187G20.1; WUGSC:H_NH0187G20.1;
GALNT14
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 14 (GalNAc-T14)
GALNT14; UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 14 (GalNAc-T14); polypeptide N-acetylgalactosaminyltransferase 14; FLJ12691; GalNac T10; GalNac T14; GalNAc-T14; GLT14_HUMAN; Polypeptide GalNAc transferase 14; Polypeptide N acetylgalactosaminyltransferase 14; pp GaNTase 14; pp-GaNTase 14; Protein UDP acetylgalactosaminyltransferase 14; Protein-UDP acetylgalactosaminyltransferase 14; UDP GalNAc:polypeptide N acetylgalactosaminyltransferase 14; UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 14; polypeptide N-acetylgalactosaminyltransferase 15; UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase T10; UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase T14; GALNT15; GalNac-T10;
MGAT1
mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase
MGAT1; mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase; GLYT1, MGAT; alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase; GLCNAC TI; GNT 1; glcNAc-T I; N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosam;
MGAT3
mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase
MGAT3; mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase; beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase; GNT III; GlcNAc-T III; N-acetylglucosaminyltransferase III; N-glycosyl-oligosaccharide-glycoprotein N;
MGAT4B
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B
MGAT4B; mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B; mannosyl (alpha 1,3 ) glycoprotein beta 1,4 N acetylglucosaminyltransferase, isoenzyme B; alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B; GnT Ivb; Alpha 1 3 mannosyl glycoprotein beta 1 4 N acetylglucosaminyltransferase; Aminyltransferase; GlcNAc T IVb; GNT IV; GNTIV; GNTIVB; Mannosyl (alpha 1 3) glycoprotein beta 1 4 N acetylglucosaminyltransferase isozyme B; MGAT 4B; N acetylglucosaminyltransferase IVb; N glycosyl oligosaccharide glycoprotein; N glycosyl oligosaccharide glycoprotein N acetylglucosaminyltransferase IVb; UDP N acetylglucosamine alpha 1 3 D mannoside beta 1 4 N acetylglucosaminyltransferase IV; UDP N acetylglucosamine alpha 1 3 D mannoside beta 1 4 N acetylglucosaminyltransferase IVb; glcNAc-T IVb; N-acetylglucosaminyltransferase IVb; alpha-1,3-mannosyl-glycoprotein beta-1,4-N-acetylglucosaminyltransferase; N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVb; mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isoenzyme B; UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IV; UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVb; GNT-IV; GNT-IVB;
MYST2
MYST histone acetyltransferase 2
MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2; HBO1; EC 2.3.1.48; HBOA; OTTHUMP00000220716; KAT7; OTTHUMP00000220718; Histone acetyltransferase binding to ORC1; MYST2; histone acetyltransferase MYST2; MYST-2; OTTHUMP00000220713; OTTHUMP00000220714; OTTHUMP00000220715; OTTHUMP00000220717; MYST histone acetyltransferase 2;
MYST3
MYST histone acetyltransferase (monocytic leukemia) 3
RUNXBP2; MOZ; Monocytic leukemia zinc finger protein; ZNF220; MOZ, YBF2/SAS3, SAS2 and TIP60 protein 3; KAT6A; EC 2.3.1.48; runt-related transcription factor binding protein 2; MGC167033; Runt-related transcription factor-binding protein 2; Zinc finger protein 220; EC 3.1.26.4; MYST3; histone acetyltransferase MYST3; MYST-3; OTTHUMP00000197392; OTTHUMP00000197394; OTTHUMP00000225722; MYST histone acetyltransferase (monocytic leukemia) 3;
MYST4
MYST histone acetyltransferase monocytic leukemia 4
MOZ, YBF2/SAS3, SAS2 and TIP60 protein 4; MOZ2; EC 2.3.1.48; MORF; KAT6B; DKFZp313G1618; qkf; FLJ90335; querkopf; OTTHUMP00000019866; Histone acetyltransferase MORF; OTTHUMP00000019867; Histone acetyltransferase MOZ2; OTTHUMP00000019869; Monocytic leukemia zinc finger protein-related factor; OTTHUMP00000019870; KIAA0383; MOZ-related factor; MYST4; histone acetyltransferase MYST4; MYST-4; OTTHUMP00000019868; MYST histone acetyltransferase (monocytic leukemia) 4;
NAT8B
N-acetyltransferase 8B (GCN5-related, putative, gene/pseudogene)
NAT8B; N-acetyltransferase 8B (GCN5-related, putative, gene/pseudogene); N acetyltransferase 8B (gene/pseudogene); probable N-acetyltransferase 8B; Hcml2; NAT8BP; Camello like protein 2; Camello-like protein 2; CML2; N acetyltransferase 8B; NAT8B_HUMAN; Probable N acetyltransferase 8B; N-acetyltransferase Camello 2; N-acetyltransferase 8B (gene/pseudogene);
PAFAH2
platelet-activating factor acetylhydrolase 2, 40kDa
PAFAH2; platelet-activating factor acetylhydrolase 2, 40kDa; platelet activating factor acetylhydrolase 2 (40kD); platelet-activating factor acetylhydrolase 2, cytoplasmic; HSD PLA2; EC 3.1.1.47; HSDPLA2; Platelet activating factor acetylhydrolase 2; Serine dependent phospholipase A2; SD-PLA2; serine-dependent phospholipase A2; HSD-PLA2;
ST8SIA4
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4
ST8SIA4; ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4; sialyltransferase 8 (alpha 2, 8 polysialytransferase) D , SIAT8D; CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase; PST; PST1; ST8Sia IV; Alpha 2 8 sialyltransferase 8D; CMP N acetylneuraminate poly alpha 2 8 sialyl transferase; Polysialyltransferase 1; Sialyltransferase 8 alpha 28 polysialytransferase D; SIAT8D; ST8 alpha N acetyl neuraminide alpha 2 8 sialyltransferase 4; ST8SIAIV; SIAT8-D; OTTHUMP00000158915; OTTHUMP00000227000; sialyltransferase 8D; polysialyltransferase-1; sialytransferase St8Sia IV; alpha-2,8-sialyltransferase 8D; sialyltransferase 8 (alpha-2, 8-polysialytransferase) D; CMP-N-acetylneuraminate-poly-alpha-2,8-sialyl transferase; ST8SIA-IV;
KAT6B
K(lysine) acetyltransferase 6B
MOZ, YBF2/SAS3, SAS2 and TIP60 protein 4; MOZ2; EC 2.3.1.48; MORF; KAT6B; DKFZp313G1618; qkf; FLJ90335; querkopf; OTTHUMP00000019866; Histone acetyltransferase MORF; OTTHUMP00000019867; Histone acetyltransferase MOZ2; OTTHUMP00000019869; Monocytic leukemia zinc finger protein-related factor; OTTHUMP00000019870; KIAA0383; MOZ-related factor; MYST4; histone acetyltransferase MYST4; MYST-4; OTTHUMP00000019868; MYST histone acetyltransferase (monocytic leukemia) 4; KAT6B; K(lysine) acetyltransferase 6B;
KAT7
K(lysine) acetyltransferase 7
KAT7; K(lysine) acetyltransferase 7; HBO1; HBOA; MYST2; ZC2HC7; histone acetyltransferase KAT7; MYST-2; lysine acetyltransferase 7; histone acetyltransferase MYST2; MYST histone acetyltransferase 2; MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2; histone acetyltransferase binding to ORC1;
KAT8
K(lysine) acetyltransferase 8
KAT8; K(lysine) acetyltransferase 8; MOF; hMOF; MYST1; ZC2HC8; histone acetyltransferase KAT8; MYST-1; lysine acetyltransferase 8; histone acetyltransferase MYST1; MYST histone acetyltransferase 1; MOZ, YBF2/SAS3, SAS2 and TIP60 protein 1; probable histone acetyltransferase MYST1; ortholog of Drosophila males absent on the first (MOF);
IAA
PLANT INDOLEACETIC ACID
Auxin; Indole; Phytohormone; Indole-3-acetic acid; INDOLEACETIC ACID; INDOLEACETIC;
BAZ2B
bromodomain adjacent to zinc finger domain, 2B
BAZ2B; bromodomain adjacent to zinc finger domain, 2B; bromodomain adjacent to zinc finger domain protein 2B; WALp4; hWALp4; FLJ45644; DKFZp434H071; DKFZp762I0516;
EMILIN2
elastin microfibril interfacer 2
EMILIN2; elastin microfibril interfacer 2; EMILIN-2; FLJ33200; FOAP 10; Elastin microfibril interface-located protein 2; extracellular glycoprotein EMILIN-2; FOAP-10; Protein FOAP-10; OTTHUMP00000158648;
NAALADL2
N-acetylated alpha-linked acidic dipeptidase-like 2
NAALADL2;N-acetylated alpha-linked acidic dipeptidase-like 2;inactive N-acetylated-alpha-linked acidic dipeptidase-like protein 2;glutamate carboxypeptidase II type non peptidase homologue;NAALADase L2;N-acetylated alpha-linked acidic dipeptidase 2;glutamate carboxypeptidase II-type non-peptidase homologue;
NAT14
N-acetyltransferase 14 (GCN5-related, putative)
NAT14; N-acetyltransferase 14 (GCN5-related, putative); N acetyltransferase 14; N-acetyltransferase 14; K562 cells derived leucine zipper like protein 1; KLP1; K562 cell derived leucine zipper like protein 1; N acetyltransferase 14 (GCN5 related, putative); K562 cell-derived leucine-zipper-like protein 1; K562 cells-derived leucine zipper-like protein 1; K562 cells-derived leucine-zipper-like protein 1;
PMAIP1
phorbol-12-myristate-13-acetate-induced protein 1
PMAIP1; phorbol-12-myristate-13-acetate-induced protein 1; APR; NOXA; protein Noxa; PMA-induced protein 1; immediate-early-response protein APR; adult T cell leukemia-derived PMA-responsive;
SPON2
spondin 2, extracellular matrix protein
SPON2; spondin 2, extracellular matrix protein; spondin-2; DIL1; M spondin; Mindin; SPON 2; Differentially expressed in cancerous and non-cancerous lung cells 1; DIL 1; DKFZp686G21139; FLJ16313; FLJ22401; FLJ34460; Spondin 2; DIL-1; M-SPONDIN;
B3GNT6
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)
B3GNT6; UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase); UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6; B3Gn T6; beta 1,3 Gn T6; beta 1,3 N acetylglucosaminyltransferase 6; beta 1,3 N acetylglucosaminyltransferase 6 protein; beta3Gn T6; core 3 synthase; UDP GlcNAc:betaGal beta 1,3 N acetylglucosaminyltransferase 6; BGnT-6; beta3Gn-T6; beta-1,3-Gn-T6; OTTHUMP00000229266; beta-1,3-N-acetylglucosaminyltransferase 6; beta-1,3-N-acetylglucosaminyltransferase protein; B3Gn-T6; IMAGE:4907098;
EFEMP1
EGF containing fibulin-like extracellular matrix protein 1
EFEMP1; EGF containing fibulin-like extracellular matrix protein 1; DHRD; DRAD; FBNL; MLVT; MTLV; S1-5; FBLN3; FIBL-3; EGF-containing fibulin-like extracellular matrix protein 1; fibulin-3; extracellular protein S1-5;
HHBVgp4
large surface antigen
HHBVgp4; large surface antigen; HBsAg; Hep B surface antigen; Hepatitis B surface antigen; Hepatitis B Virus major surface antigen; Hepatitis B virus S antigen; L glycoprotein; L HBsAg; Large envelope protein; Large S protein; Large surface protein; LHB; Major surface antigen;
NAA11
N(alpha)-acetyltransferase 11, NatA catalytic subunit
NAA11; N(alpha)-acetyltransferase 11, NatA catalytic subunit; ARD1 homolog B (S. cerevisiae) , ARD1B; N-alpha-acetyltransferase 11; ARD2; hARD2; ARD1 homolog B; natA catalytic subunit; human arrest defective 2; N-alpha-acetyltransferase 11, NatA catalytic;
NAA15
N(alpha)-acetyltransferase 15, NatA auxiliary subunit
NAA15; N(alpha)-acetyltransferase 15, NatA auxiliary subunit; NARG1, NMDA receptor regulated 1; N-alpha-acetyltransferase 15, NatA auxiliary subunit; FLJ13340; NATH; TBDN100; tubedown-1; protein tubedown-1; NMDA receptor regulated 1; gastric cancer antig;
NAA38
N(alpha)-acetyltransferase 38, NatC auxiliary subunit
NAA38; N(alpha)-acetyltransferase 38, NatC auxiliary subunit; LSM8, LSM8 homolog, U6 small nuclear RNA associated (S. cerevisiae); N-alpha-acetyltransferase 38, NatC auxiliary subunit; YJR022W; MAK31-like protein; U6 snRNA-associated Sm-like protein LSm8;
ADRB2
adrenoceptor beta 2, surface
ADRB2; adrenoceptor beta 2, surface; BAR; B2AR; ADRBR; ADRB2R; BETA2AR; beta-2 adrenergic receptor; beta-2 adrenoceptor; beta-2 adrenoreceptor; catecholamine receptor; adrenoceptor beta 2 surface; adrenergic, beta-2-, receptor, surface;
GALNT2
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2)
GALNT2; UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2); polypeptide N-acetylgalactosaminyltransferase 2; GalNAc T2; GalNAc-T2; GALT2_HUMAN; GaNTase 2; Polypeptide GalNAc transferase 2; Polypeptide N acetylgalactosaminyltransferase 2 soluble form; Polypeptide N-acetylgalactosaminyltransferase 2 soluble form; pp GaNTase 2; pp-GaNTase 2; Protein UDP acetylgalactosaminyltransferase 2; Protein-UDP acetylgalactosaminyltransferase 2; UDP GalNAc transferase 2; UDP N acetyl alpha D galactosamine:polypeptide N acetylgalactosaminyltransferase 2; UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2; UDP-GalNAc transferase 2;
GCNT1
glucosaminyl (N-acetyl) transferase 1, core 2
GCNT1; glucosaminyl (N-acetyl) transferase 1, core 2; glucosaminyl (N acetyl) transferase 1, core 2 (beta 1,6 N acetylglucosaminyltransferase) , NACGT2; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase; beta 1; 3 galact;
MKLN1
muskelin 1, intracellular mediator containing kelch motifs
MKLN1; muskelin 1, intracellular mediator containing kelch motifs; muskelin; TWA2; MKLN 1; OTTHUMP00000206857; OTTHUMP00000207137;
ST8SIA1
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1
ST8SIA1; ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1; sialyltransferase 8 (alpha N acetylneuraminate: alpha 2,8 sialytransferase, GD3 synthase) A , SIAT8, SIAT8A; alpha-N-acetylneuraminide alpha-2,8-sialyltransferase; ST8Sia I; gangliosid;
MUC17
mucin 17, cell surface associated
MUC17; mucin 17, cell surface associated; mucin-17; MUC-3; MUC-17; membrane mucin MUC17; secreted mucin MUC17; small intestinal mucin-3; small intestinal mucin MUC3; MUC3;
A4GNT
alpha-1,4-N-acetylglucosaminyltransferase
A4GNT; alpha-1,4-N-acetylglucosaminyltransferase; alpha4GnT; MGC149493;
AADACL2
arylacetamide deacetylase-like 2
AADACL2; arylacetamide deacetylase-like 2; MGC72001; Arylacetamide deacetylase like 2 [Precursor];
AADACL3
arylacetamide deacetylase-like 3
AADACL3; arylacetamide deacetylase-like 3; OTTHUMG00000001887; ADCL3_HUMAN; RP11-474O21.3;
AADACL4
arylacetamide deacetylase-like 4
AADACL4; arylacetamide deacetylase-like 4; OTTHUMG00000001889; ADCL4_HUMAN; Arylacetamide deacetylase like 4;
ASMTL
acetylserotonin O-methyltransferase-like
ASMTL; acetylserotonin O-methyltransferase-like; N-acetylserotonin O-methyltransferase-like protein; Acetylserotonin N methyltransferase like; Acetylserotonin O methyltransferase like; ASMTLX; ASMTLY; ASTML; N acetylserotonin O methyltransferase like protein; acetylserotonin N-methyltransferase-like;
AMMECR1
Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1
AMMECR1; Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1; AMME syndrome candidate gene 1 protein; Alport syndrome mental retardation midface hypoplasia and elliptocytosis chromosomal region gene 1; AMMECR 1; AMMECR1 protein; AMMERC1; OTTHUMP00000023851;
B3GNT4
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4
B3GNT4; UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4; B3GN T4; beta3Gn T4; BGnT-4; beta-1,3-Gn-T4; beta-1,3-N-acetylglucosaminyltransferase 4; beta-1,3-N-acetylglucosaminyltransferase bGn-T4; B3GN-T4; beta3Gn-T4;
B3GNT5
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5
B3GNT5; UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5; B3GN T5; beta3Gn T5; B3GN-T5; Beta 1,3 N acetyglucosaminyltransferase Lc3 synthase; Beta 1,3 N acetylglucosaminyltransferase 5; Beta 1,3-N acetylglucosaminyltransferase bGnT5; Beta-1,3-Gn-T5; Beta3Gn-T5; beta3GnT5; BGnT-5; EC 2.4.1.-; Lactotriaosylceramide synthase; Lc(3)Cer synthase; Lc3 synthase; UDP GlcNAc:betaGal beta 1,3 N acetylglucosaminyltransferase 5; OTTHUMP00000212932; beta-1,3-N-acetylglucosaminyltransferase 5; beta-1,3-N-acetylglucosaminyltransferase bGnT-5; beta 1,3 N-acetyglucosaminyltransferase Lc3 synthase;
BAZ2A
bromodomain adjacent to zinc finger domain, 2A
BAZ2A; bromodomain adjacent to zinc finger domain, 2A; TIP5; WALp3; bromodomain adjacent to zinc finger domain protein 2A; hWALp3; TTF-I interacting peptide 5; TTF-I-interacting protein 5; transcription termination factor I-interacting protein 5;
B3GALNT1
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)
B3GALNT1; beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group); B3GALT3, UDP Gal:betaGlcNAc beta 1,3 galactosyltransferase, polypeptide 3 (Globoside blood group) , UDP GalNAc:betaGlcNAc beta 1,3 galactosaminyltransferase, polypeptide 1 (;
GCNT4
glucosaminyl (N-acetyl) transferase 4, core 2
GCNT4; glucosaminyl (N-acetyl) transferase 4, core 2; glucosaminyl (N acetyl) transferase 4, core 2 (beta 1,6 N acetylglucosaminyltransferase); beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4; beta 1; 3 galactosyl O glycosyl glycoprotein beta 1; 6 N acetylglucosaminyltransferase 4; C2GNT3; core 2 beta 1; 6 N acetylglucosaminyltransferase 3; Core 2 (beta-1,6-N-acetylglucosaminyltransferase); Core 2 branching enzyme 3; Core2 GlcNAc transferase 3; Glucosaminyl (N-acetyl) transferase 4; core 2-branching enzyme 3; core2-GlcNAc-transferase 3; core 2 beta-1,6-N-acetylglucosaminyltransferase 3; glucosaminyl (N-acetyl) transferase 4, core 2 (beta-1,6-N-acetylglucosaminyltransferase);
B4GALNT3
beta-1,4-N-acetyl-galactosaminyl transferase 3
B4GALNT3; beta-1,4-N-acetyl-galactosaminyl transferase 3; N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 2; B4GalNac T3; FLJ16224; FLJ40362; NGalNAc-T2; beta4GalNAcT3; Beta4GalNAc-T3; beta-1,4-N-acetylgalactosaminyltransf;
BAHD1
bromo adjacent homology domain containing 1
BAHD1; bromo adjacent homology domain containing 1; bromo adjacent homology domain-containing 1 protein; BAH domain-containing protein 1;
CHST14
carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14
CHST14; carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14; D4ST1, dermatan 4 sulfotransferase 1; carbohydrate sulfotransferase 14; D4ST 1; HD4ST; D4st1; RP23-286G12.2; 2600016L03Rik; ATCS; Carbohydrate (N acetylgalactosamine 4 0) sulfotransferase 14; CHSTE_HUMAN; D4ST-1; Dermatan 4-sulfotransferase 1; hD4ST1; UNQ1925/PRO4400; dermatan 4 sulfotransferase 1; HNK1ST;
CHST6
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 6
CHST6; carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 6; MCDC1; carbohydrate sulfotransferase 6; C GlcNAc6ST; Carbohydate sulfotransferase 6; Carbohydrate (N acetylglucosamine 6 O) sulfotransferase 6; Corneal N acetylglucosamine 6 sulfotransferase; Galactose N acetylglucosamine N acetylglucosamine 6 O sulfotransferase 4 beta; GlcNAc6ST 5; GST4 beta; hCGn6ST; Macular dystrophy corneal 1; gn6st-5; GST4-beta; C-GlcNAc6ST; glcNAc6ST-5; N-acetylglucosamine 6-O-sulfotransferase 5; corneal N-acetylglucosamine 6-sulfotransferase; corneal N-acetylglucosamine-6-O-sulfotransferase; galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 4-beta;
CHST8
carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 8
CHST8; carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 8; carbohydrate sulfotransferase 8; GALNAC 4 ST1; Carbohydrate (N acetylgalactosamine 4 0) sulfotransferase 8; CHST 8; GalNAc 4 O sulfotransferase 1; GalNAc4ST 1; GalNAc4ST; GALNAC4ST1; N acetylgalactosamine 4 O sulfotransferase 1; N acetylgalactosamine 4 O sulfotransferase; galNAc4ST-1; GALNAC-4-ST1; GalNAc-4-O-sulfotransferase 1; N-acetylgalactosamine-4-O-sulfotransferase 1;
CHST2
carbohydrate (N-acetylglucosamine-6-O) sulfotransferase 2
CHST2; carbohydrate (N-acetylglucosamine-6-O) sulfotransferase 2; carbohydrate sulfotransferase 2; C6ST; Chts2; Gn6st; GST 2; AI428561; AW121776; C130041E03Rik; Carbohydrate (chondroitin 6/keratan) sulfotransferase 2; CHST2_HUMAN; Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 2; GlcNAc6ST; GlcNAc6ST-1; Gn6st-1; GST-2; GST2; N-acetylglucosamine 6-O-sulfotransferase 1; N-acetylglucosamine 6-O-sulfotransferase;
CSGALNACT1
chondroitin sulfate N-acetylgalactosaminyltransferase 1
CSGALNACT1; chondroitin sulfate N-acetylgalactosaminyltransferase 1; ChGn; chondroitin beta1; 4 N acetylgalactosaminyltransferase; CSGalNAcT 1; FLJ11264; 4-N-acetylgalactosaminyltransferase 1; Beta4GalNAcT 1; beta4GalNAcT; Beta4GalNAcT-1; Beta4GalNAcT1; CGAT1_HUMAN; Chondroitin beta-1; Chondroitin beta1 4 N acetylgalactosaminyltransferase; Chondroitin beta1 4 N acetylgalactosaminyltransferase 1; Chondroitin sulfate N acetylgalactosaminyltransferase 1; CsGalNAcT-1; FLJ13760; OTTHUMP00000161400; OTTHUMP00000224750; OTTHUMP00000224752; chondroitin beta1,4 N-acetylgalactosaminyltransferase; chondroitin beta-1,4-N-acetylgalactosaminyltransferase 1;
CSGALNACT2
chondroitin sulfate N-acetylgalactosaminyltransferase 2
CSGALNACT2; chondroitin sulfate N-acetylgalactosaminyltransferase 2; chondroitin beta1; 4 N acetylgalactosaminyltransferase 2; GALNACT 2; GALNACT2; MGC40204; PRO0082; DKFZp686H13226; FLJ43310; CHGN2; beta4GalNAcT-2; beta 4 GalNAcT-2; chondroitin sulfate GalNAcT-2; chondroitin beta1,4 N-acetylgalactosaminyltransferase 2; chondroitin beta-1,4-N-acetylgalactosaminyltransferase 2; GALNACT-2;
COLQ
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase
COLQ; collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase; acetylcholinesterase collagenic tail peptide; acetylcholinesterase associated collagen; AChE Q subunit; collagenic tail of endplate acetylcholinesterase; EAD; single strand of homotrimeric collagen like tail subunit of asymmetric acetylcholinesterase; Acetylcholinesterase collagen-like tail subunit isoform I; Acetylcholinesterase collagenic tail peptide precursor; Acetylcholinesterase-associated collagen; asymmetric acetylcholinesterase; COLQ_HUMAN; single strand of homotrimeric collagen-like tail subunit of asymmetric acetylcholinesterase;
CRAT
carnitine O-acetyltransferase
CRAT; carnitine O-acetyltransferase; carnitine acetyltransferase; CAT1; Carnitine acetylase; Carnitine O acetyltransferase; CAT;
NAA60
N(alpha)-acetyltransferase 60, NatF catalytic subunit
NAA60; N(alpha)-acetyltransferase 60, NatF catalytic subunit; N acetyltransferase 15 (GCN5 related, putative) , NAT15; N-alpha-acetyltransferase 60; FLJ14154; FLJ11693; N-acetyltransferase 15; NAT15; natF catalytic subunit; N-acetyltransferase 15 (GCN5-related, putative);
EMILIN3
elastin microfibril interfacer 3
EMILIN3; elastin microfibril interfacer 3; C20orf130, elastin microfibril interfacer 5 , EMILIN5; EMILIN-3; chromosome 20 open reading frame 130; dJ620E11.4; EMILIN5; 1110013O17Rik; C20orf130; DKFZp434A2410; Elastin microfibril interface-located protein 3; Elastin microfibril interface-located protein 5; Elastin microfibril interfacer 5; EMIL3_HUMAN; EMILIN T; EMILIN-5; RP23-393F23.5; RP4-620E11.1;
GALNT11
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 11 (GalNAc-T11)
GALNT11; UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 11 (GalNAc-T11); polypeptide N-acetylgalactosaminyltransferase 11; FLJ21634; GALNAC-T11; pp-GaNTase 11; polypeptide GalNAc transferase 11; protein-UDP acetylgalactos;
GALNT12
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 12 (GalNAc-T12)
GALNT12; UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 12 (GalNAc-T12); polypeptide N-acetylgalactosaminyltransferase 12; FLJ21212; CRCS1; GalNAc T12; GalNAc-T12; GalNAcT12; GALNT 12; GLT12_HUMAN; Polypeptide GalNAc transferase 12; Polypeptide N acetylgalactosaminyltransferase 12; pp GaNTase 12; pp-GaNTase 12; Protein UDP acetylgalactosaminyltransferase 12; Protein-UDP acetylgalactosaminyltransferase 12; UDP GalNAc polypeptide N acetylgalactosaminyltransferase 12; UDP GalNAc polypeptide N acetylgalactosaminyltransferase; UDP N acetyl alpha D galactosamine polypeptide N acetylgalactosaminyltransferase 12; UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 12; OTTHUMP00000021781; colorectal cancer, susceptibility to 1;
FREM2
FRAS1 related extracellular matrix protein 2
FREM2; FRAS1 related extracellular matrix protein 2; FRAS1-related extracellular matrix protein 2; ECM3 homolog;
GNE
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase
GNE; glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase; IBM2, UDP N acetylglucosamine 2 epimerase/N acetylmannosamine kinase; bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase; Uae1; IBM2; 2310066H07Rik; Bifunctional UDP N acetylglucosamine 2 epimerase/N acetylmannosamine kinase; DMRV; ManAc kinase; N acylmannosamine kinase; NM; RP23-209M8.6; UDP GlcNAc 2 epimerase; UDP GlcNAc 2 epimerase/ManAc kinase; Uridine diphosphate N acetylglucosamine 2 epimerase; N-acylmannosamine kinase; UDP-GlcNAc-2-epimerase/ManAc kinase; UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase; UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase; GLCNE;
GCAT
glycine C-acetyltransferase
GCAT; glycine C-acetyltransferase; glycine C acetyltransferase (2 amino 3 ketobutyrate coenzyme A ligase); 2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial; 2 amino 3 ketobutyrate coenzyme A ligase; KBL; AKB ligase; aminoacetone synthase; glycine a;
NAT8L
N-acetyltransferase 8-like (GCN5-related, putative)
NAT8L; N-acetyltransferase 8-like (GCN5-related, putative); N acetyltransferase 8 like; N-acetylaspartate synthetase; FLJ37478; Hcml3; CML3; N acetyltransferase 8 like (GCN5 related, putative); NAT8 like; NAA synthetase; camello-like protein 3; NACED; NAT8-LIKE;
KAT6A
K(lysine) acetyltransferase 6A
KAT6A; K(lysine) acetyltransferase 6A; RUNXBP2; MOZ; Monocytic leukemia zinc finger protein; ZNF220; MOZ, YBF2/SAS3, SAS2 and TIP60 protein 3; KAT6A; EC 2.3.1.48; runt-related transcription factor binding protein 2; MGC167033; Runt-related transcription factor-binding protein 2; Zinc finger protein 220; EC 3.1.26.4; MYST3; histone acetyltransferase MYST3; MYST-3; OTTHUMP00000197392; OTTHUMP00000197394; OTTHUMP00000225722; MYST histone acetyltransferase (monocytic leukemia) 3;
FREM1
FRAS1 related extracellular matrix 1
FREM1; FRAS1 related extracellular matrix 1; C9orf154, chromosome 9 open reading frame 154; FRAS1-related extracellular matrix protein 1; C9orf143; C9orf145; DKFZp686M16108; FLJ25461; TILRR; BC037594; D630008K06; MOTA; BNAR; C9orf154; D430009N09; FREM 1; FREM1_HUMAN; Heb; Protein QBRICK; QBRICK; RGD1306981; RP11-265B7.2; RP23-410K19.1; extracellular matrix protein QBRICK;
GALNS
galactosamine (N-acetyl)-6-sulfate sulfatase
GALNS; galactosamine (N-acetyl)-6-sulfate sulfatase; N-acetylgalactosamine-6-sulfatase; GALNAC6S; GAS; Morquio syndrome; mucopolysaccharidosis type IVA; Chondroitinase; Chondroitinsulfatase; FLJ00319; FLJ17434; FLJ42844; FLJ98217; Galactosamine (N acetyl) 6 sulfate sulfatase; Galactose 6 sulfate sulfatase; GalNAc6S sulfatase; mFLJ00319; MPS4A; N acetylgalactosamine 6 sulfatase; N acetylgalactosamine 6 sulfate sulfatase; galactose-6-sulfate sulfatase; N-acetylgalactosamine-6-sulfate sulfatase;
GCNT2
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group)
GCNT2; glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group); cataract, congenital , CCAT, GCNT5, glucosaminyl (N acetyl) transferase 2, I branching enzyme , glucosaminyl (N acetyl) transferase 2, I branching enzyme (Ii blood group) , glucosaminyl (N acetyl) transferase 5 , II, NACGT1; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase; bA360O19.2; bA421M1.1; IGNT; Ii blood group; NAGCT1; ULG3; unassigned linkage group 3; Beta 1 6 N acetylglucosaminyltransferase 2; CCAT; GCNT 2; GCNT2C; GCNT5; Glucosaminyl (N acetyl) transferase 2 I branching enzyme (I blood group); Glucosaminyl (N acetyl) transferase 2 I branching enzyme; I beta 1 6 N acetylglucosaminyltransferase; I branching beta 1 6 acetylglucosaminyltransferase; I branching enzyme; II; MGC163396; N acetylglucosaminyltransferase; N acetyllactosaminide beta 1 6 N acetylglucosaminyltransferase; NACGT1; I-branching enzyme; OTTHUMP00000016015; OTTHUMP00000016018; OTTHUMP00000016021; N-acetylglucosaminyltransferase; I beta-1,6-N-acetylglucosaminyltransferase; beta-1,6-N-acetylglucosaminyltransferase 2; I-branching beta-1,6-acetylglucosaminyltransferase; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase;
GCNT3
glucosaminyl (N-acetyl) transferase 3, mucin type
GCNT3; glucosaminyl (N-acetyl) transferase 3, mucin type; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 3; C2/4GnT; C2GnT M; C2GnT2; hC2GnT-M; C2GnT-mucin type; beta1,6GlcNAc-transferase; beta1,6-N-acetylglucosaminyl;
HEXIM2
hexamethylene bis-acetamide inducible 2
HEXIM2; hexamethylene bis-acetamide inducible 2; protein HEXIM2; FLJ32384; MAQ1 paralog; hexamthylene bis-acetamide inducible 2; hexamethylene bis-acetamide-inducible protein 2; hexamethylene-bis-acetamide-inducible transcript 2; L3;
GALNT3
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3)
GALNT3; UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3); polypeptide N-acetylgalactosaminyltransferase 3; GalNAc T3; HFTC; HHS; DKFZp686C10199; EC 2.4.1.41; GalNAc transferase 3; GalNAc-T3; GalNAcT3; GALT3_HUMAN; MGC61909; OTTHUMP00000204915; OTTHUMP00000204919; Polypeptide GalNAc transferase 3; Polypeptide N acetylgalactosaminyltransferase 3; pp-GaNTase 3; ppGaNTase 3; Protein UDP acetylgalactosaminyltransferase 3; Protein-UDP acetylgalactosaminyltransferase 3; RP23-306G16.2; UDP GalNAc:polypeptide N acetylgalactosaminyltransferase 3; UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3; UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3; polypeptide GalNAc-transferase T3;
GALNT4
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 4 (GalNAc-T4)
GALNT4; UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 4 (GalNAc-T4); polypeptide N-acetylgalactosaminyltransferase 4; GalNAc T4; EC 2.4.1.41; GalNAc transferase 4; GalNAc-T4; GalNAcT4; GALT4_HUMAN; N-acetylgalactosaminyltransferase 4 (GalNAc-T4); Polypeptide GalNAc transferase 4; pp GaNTase 4; pp-GaNTase 4; Protein UDP acetylgalactosaminyltransferase 4; Protein-UDP acetylgalactosaminyltransferase 4; UDP GalNAc:polypeptide N-acetylgalactosaminyltransferase 4; UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 4; UDP-N-acetyl-alpha-D-galactosamine:polypeptide;
GALNT5
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 5 (GalNAc-T5)
GALNT5; UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 5 (GalNAc-T5); polypeptide N-acetylgalactosaminyltransferase 5; pp-GaNTase 5; polypeptide GalNAc transferase 5; protein-UDP acetylgalactosaminyltransferase 5; UDP-Gal;
GALNT9
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9)
GALNT9; UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9); polypeptide N-acetylgalactosaminyltransferase 9; GALNAC T9; Polypeptide GalNAc transferase 9; Polypeptide N acetylgalactosaminyltransferase 9; pp GaNTase 9; Protein UDP acetylgalactosaminyltransferase 9; UDP GalNAc polypeptide N acetylgalactosaminyltransferase 9; pp-GaNTase 9; GalNAc transferase 9; protein-UDP acetylgalactosaminyltransferase 9; UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 9; UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase 9; GALNAC-T9;
GALNTL1
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 1
GALNTL1; UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 1; putative polypeptide N-acetylgalactosaminyltransferase-like protein 1; KIAA1130; GalNAc T like protein 1; GALNACT16; GALNT16; Human GalNAc T16 DNA sequence; mpp-GalNAc-T16; N acetylgalactosaminyltransferase like protein 1; Polypeptide GalNAc transferase like protein 1; polypeptide N acetylgalactosaminyltransferase 16; pp GaNTase like protein 1; Protein UDP acetylgalactosaminyltransferase like protein 1 3 UDP GalNAc : polypeptide; UDP N acetyl alpha D galactosamine : polypeptide N acetylgalactosaminyltransferase like 1; UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 1; galNAc-T-like protein 1; pp-GaNTase-like protein 1; polypeptide GalNAc transferase-like protein 1; polypeptide N-acetylgalactosaminyltransferase 16; protein-UDP acetylgalactosaminyltransferase-like protein 1;
GALNTL2
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 2
GALNTL2; UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 2; polypeptide N-acetylgalactosaminyltransferase-like protein 2; GALNT7; galNAc-T-like protein 2; pp-GaNTase-like protein 2; UDP-GalNAc transferase T15; polypep;
GALNTL5
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 5
GALNTL5; UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 5; GALNT15, UDP N acetyl alpha D galactosamine:polypeptide N acetylgalactosaminyltransferase 15; putative polypeptide N-acetylgalactosaminyltransferase-like pr;
GNPTAB
N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits
GNPTAB; N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits; GNPTA; N-acetylglucosamine-1-phosphotransferase subunits alpha/beta; KIAA1208; MGC4170; EC=2.7.8.17; GlcNAc-1-phosphotransferase subunits alpha/beta; GNPTA_HUMAN; N-acetylglucosamine-1-phosphotransferase subunit beta; Stealth protein GNPTAB; UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta; GlcNAc phosphotransferase; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosamine; glucosamine (UDP-N-acetyl)-lysosomal-enzyme N-acetylglucosamine phosphotransferase; ICD;
GNPTG
N-acetylglucosamine-1-phosphate transferase, gamma subunit
GNPTG; N-acetylglucosamine-1-phosphate transferase, gamma subunit; C16orf27, chromosome 16 open reading frame 27 , GNPTAG, N acetylglucosamine 1 phosphotransferase, gamma subunit; N-acetylglucosamine-1-phosphotransferase subunit gamma; c316G12.3; CAB56184; GlcNAc phosphotransferase gamma subunit; GlcNAc-1-phosphotransferase subunit gamma; GNPTAG; LP2537; N-acetylglucosamine-1-phosphate transferase gamma subunit; RJD9; UDP-N-acetylglucosamine-1-phosphotransferase subunit gamma; C16orf27;
TAAR3
trace amine-associated receptor 3
TAAR3; trace amine-associated receptor 3; G protein coupled receptor 57; GPR 57; GPR58; Probable G protein coupled receptor GPR57; TAAR 3; TAAR2; Trace amine associated receptor 3; taR-3; trace amine receptor 3;
TAAR2
trace amine associated receptor 2
TAAR2; trace amine associated receptor 2; G protein coupled receptor 58 , GPR58; trace amine-associated receptor 2; G protein coupled receptor 58; phBL5; taR-2; trace amine receptor 2; G protein-coupled receptor 58; G-protein coupled receptor 58; GPR58;
GOT1L1
glutamic-oxaloacetic transaminase 1-like 1
GOT1L1; glutamic-oxaloacetic transaminase 1-like 1; putative aspartate aminotransferase, cytoplasmic 2; MGC33309; transaminase A-like protein 1; glutamate oxaloacetate transaminase 1-like protein 1;
TAAR8
trace amine associated receptor 8
TAAR8; trace amine associated receptor 8; GPR102, trace amine receptor 5 , TRAR5; trace amine-associated receptor 8; TA5; TAR5; G protein coupled receptor 102; Trace amine assiciated receptor 8; Trace amine receptor 5; TRAR5; trace amine receptor 8; G protein-coupled receptor 102; G-protein coupled receptor 102; TaR-5; TaR-8; GPR102;
IAH1
isoamyl acetate-hydrolyzing esterase 1 homolog (S. cerevisiae)
IAH1; isoamyl acetate-hydrolyzing esterase 1 homolog (S. cerevisiae); isoamyl acetate-hydrolyzing esterase 1 homolog; IAH1_HUMAN; MGC102860;
INSL4
insulin-like 4 (placenta)
INSL4; insulin-like 4 (placenta); early placenta insulin-like peptide; EPIL; early placenta insulin like peptide (EPIL); Early placenta insulin like peptide A chain; Early placenta insulin like peptide; Early placenta insulin like peptide B chain; Early placenta insulin-like peptide A chain; INSL4_HUMAN; insulin like 4; insulin like 4 (placenta); Insulin like peptide 4; Insulin-like peptide 4; OTTHUMP00000021025; Placentin; early placenta insulin-like peptide (EPIL);
NAA35
N(alpha)-acetyltransferase 35, NatC auxiliary subunit
NAA35; N(alpha)-acetyltransferase 35, NatC auxiliary subunit; MAK10, MAK10 homolog, amino acid N acetyltransferase subunit (S. cerevisiae); N-alpha-acetyltransferase 35, NatC auxiliary subunit; bA379P1.1; FLJ21613; FLJ22643; protein MAK10 homolog; cornea;
NAA30
N(alpha)-acetyltransferase 30, NatC catalytic subunit
NAA30; N(alpha)-acetyltransferase 30, NatC catalytic subunit; C14orf35, chromosome 14 open reading frame 35 , N acetyltransferase 12 , N acetyltransferase 12 (GCN5 related, putative) , NAT12; N-alpha-acetyltransferase 30; FLJ35355; MAK3; Mak3p; C14orf35; Chromosome 14 open reading frame 35; MAK 3; MGC141884; MGC141885; N acetyltransferase 12 (GCN5 related putative); N acetyltransferase 12; N acetyltransferase MAK3 homolog; NAT12; Putative N acetyltransferase; natC catalytic subunit; putative N-acetyltransferase; N-acetyltransferase MAK3 homolog; N-acetyltransferase 12 (GCN5-related, putative); N-alpha-acetyltransferase 30, NatC catalytic subunit;
NDST4
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 4
NDST4; N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 4; bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 4; BSST4; N-heparan sulfate sulfotransferase 4; NHSST 4; N-HSST 4; glucosaminyl N-deacetylase/N-sulfotransferase 4; NDST-4; NHSST4;
MEPE
matrix extracellular phosphoglycoprotein
MEPE; matrix extracellular phosphoglycoprotein; matrix, extracellular phosphoglycoprotein with ASARM motif (bone); osteoblast/osteocyte factor 45; OF45;
MGAT4C
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative)
MGAT4C; mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative); alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C; HGNT IV H; gnT-IVc; glcNAc-T IVc; N-acetylglucosaminyltransferase IVc; N-a;
NAT9
N-acetyltransferase 9 (GCN5-related, putative)
NAT9; N-acetyltransferase 9 (GCN5-related, putative); N acetyltransferase 9; N-acetyltransferase 9; DKFZP564C103; EBSP; Embryo brain specific protein; Nacetyltransferase 9; embryo brain-specific protein; EBSP, hNATL;
MUC13
mucin 13, cell surface associated
MUC13; mucin 13, cell surface associated; down regulated in colon cancer 1 , DRCC1, mucin 13, epithelial transmembrane; mucin-13; down-regulated in colon cancer 1; mucin 13, epithelial transmembrane; DRCC1; MUC-13; FLJ20063;
MUC15
mucin 15, cell surface associated
MUC15; mucin 15, cell surface associated; mucin-15; PAS3; MUC-15; PASIII;
MUC20
mucin 20, cell surface associated
MUC20; mucin 20, cell surface associated; mucin-20; FLJ14408; KIAA1359; MUC 20; MUC-20; MUC20_HUMAN; Mucin 20; Transmembrane mucin MUC20S;
MUC3B
mucin 3B, cell surface associated
MUC3B; mucin 3B, cell surface associated; mucin 3B; mucin-3B; Intestinal mucin 3B; MUC 3A; MUC 3B; MUC3; MUC3A; MUC-3B; intestinal mucin-3B; intestinal mucin MUC3B;
NAA40
N(alpha)-acetyltransferase 40, NatD catalytic subunit, homolog (S. cerevisiae)
NAA40; N(alpha)-acetyltransferase 40, NatD catalytic subunit, homolog (S. cerevisiae); N acetyltransferase 11 , N acetyltransferase 11 (GCN5 related, putative) , NAT11; N-alpha-acetyltransferase 40; FLJ13848; NatD catalytic subunit; N-acetyltransferase 11; NAA40_HUMAN; NAT11; N-alpha acetyl transferase 40; N-acetyltransferase 11 (GCN5-related, putative); N-alpha-acetyltransferase 40, NatD catalytic subunit; PATT1;
NAA25
N(alpha)-acetyltransferase 25, NatB auxiliary subunit
NAA25; N(alpha)-acetyltransferase 25, NatB auxiliary subunit; NAP1; MDM20; C12orf30; N-alpha-acetyltransferase 25, NatB auxiliary subunit; natB complex subunit MDM20; mitochondrial distribution and morphology 20; N-terminal acetyltransferase B complex subunit NAA25;
NAA50
N(alpha)-acetyltransferase 50, NatE catalytic subunit
NAA50; N(alpha)-acetyltransferase 50, NatE catalytic subunit; MAK3, Mak3 homolog (S. cerevisiae) , N acetyltransferase 13 , N acetyltransferase 13 (GCN5 related) , NAT13; N-alpha-acetyltransferase 50; FLJ13194; NAT5; San; MAK3; hNAT5; hSAN; Mak3 homolog (S. cerevisiae); Mak3 homolog; N-acetyltransferase 13 (GCN5-related); N-acetyltransferase 13; N-acetyltransferase 5; N-acetyltransferase san homolog; N-alpha-acetyltransferase 50, NatE catalytic subunit; NAT 5; NAT13; separation anxiety; natE catalytic subunit;
NOTUM
notum pectinacetylesterase homolog
NOTUM; notum pectinacetylesterase homolog (Drosophila); protein notum homolog;
SIGMAR1
sigma non-opioid intracellular receptor 1
SIGMAR1; sigma non-opioid intracellular receptor 1; opioid receptor, sigma 1 , OPRS1; SR BP1; SR-BP; SIG-1R; sigma1R; hSigmaR1; SR31747 binding protein 1; sigma 1-type opioid receptor; aging-associated gene 8 protein; SRBP; ALS16; OPRS1; SR-BP1; MGC3851;
PLAC1
placenta-specific 1
PLAC1; placenta-specific 1; placenta-specific protein 1; cancer/testis antigen 92; CT92; PLAC1_HUMAN; Placenta specific 1;
PLAC4
placenta-specific 4
PLAC4; placenta-specific 4; C21orf115, chromosome 21 open reading frame 115; placenta-specific protein 4; MGC126664; MGC126666; PRED78; C21orf115; chromosome 21 open reading frame 115; D21S418E; PLAC4_HUMAN; Placenta specific protein 4;
TAAR5
trace amine associated receptor 5
TAAR5; trace amine associated receptor 5; trace amine-associated receptor 5; PNR; taR-5; trace amine receptor 5; putative neurotransmitter receptor; RP11-295F4.5; MGC138414; MGC138416;
AANAT
aralkylamine N-acetyltransferase
AANAT; aralkylamine N-acetyltransferase; arylalkylamine N acetyltransferase; serotonin N-acetyltransferase; serotonin N acetyltransferase; SNAT; serotonin acetylase; arylalkylamine N-acetyltransferase; DSPS;
SAT2
spermidine/spermine N1-acetyltransferase family member 2
SAT2; spermidine/spermine N1-acetyltransferase family member 2; spermidine/spermine N1 acetyltransferase 2; diamine acetyltransferase 2; diamine N acetyltransferase 2; SSAT2; Amino acid transporter A2; ATA2; Polyamine N acetyltransferase; Protein 40 9 1; SNAT2; Solute carrier family 38 member 2; Spermidine/spermine N1 acetyltransferase family member 2; System A amino acid transporter 2; System A transporter 1; System N amino acid transporter 2; diamine N-acetyltransferase 2; polyamine N-acetyltransferase 2; thialysine N-epsilon-acetyltransferase; spermidine/spermine N1-acetyltransferase 2; spermidine/spermine N(1)-acetyltransferase 2;
SIAE
sialic acid acetylesterase
SIAE; sialic acid acetylesterase; YSG2, Ysg2 homolog (mouse); sialate O-acetylesterase; CSE C; LSE; MGC87009; sialic acid specific acetylesterase II; CSEC; Cytosolic sialic acid 9 O acetylesterase homolog; H Lse; HLse; Sialate O acetylesterase; Sialic acid specific 9 O acetylesterase; YSG2; Ysg2 homolog; H-Lse; sialic acid-specific acetylesterase II; cytosolic sialic acid 9-O-acetylesterase homolog; AIS6; CSE-C;
SLC35D1
solute carrier family 35 (UDP-glucuronic acid/UDP-N-acetylgalactosamine dual transporter), member D1
SLC35D1; solute carrier family 35 (UDP-glucuronic acid/UDP-N-acetylgalactosamine dual transporter), member D1; UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter; KIAA0260; UGTREL7; MGC138236; S35D1_HUMAN; Solute carrier family 35 member D1; UDP galactose transporter related 7; UDP-galactose transporter-related protein 7; UDP-GlcA/UDP-GalNAc transporter; UDP-galactose transporter-related 7;
ST8SIA6
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6
ST8SIA6; ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6; sialyltransferase 8F (alpha 2, 8 sialyltransferase) , SIAT8F; alpha-2,8-sialyltransferase 8F; ST8Sia VI; SIAT8-F; ST8SiaVI; sialytransferase St8Sia VI; alpha-2,8-sialyltransferase 8F v;
ST6GALNAC2
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2
ST6GALNAC2; ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2; sialyltransferase 7 ((alpha N acetylneuraminyl 2,3 beta galactosyl 1,3) N acetyl galactosaminide alpha 2,6 sialyltransferase) , sialyltransferase like 1 , SIAT7, SIAT7B, SIATL1; alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2; ST6GalNAII; STHM; SAITL1; (alpha N acetylneuraminyl 2 3 beta galactosyl 1 3) N acetyl galactosaminide alpha 2 6 sialyltransferase; (alpha N acetylneuraminyl 2 3 beta galactosyl 1 3) N acetyl galactosaminide B; Alpha N acetylgalactosaminide alpha 2 6 sialyltransferase 2; FLJ45660; GalNAc alpha 2 6 sialyltransferase II; Sialyltransferase 7; Sialyltransferase 7B; Sialyltransferase like 1; Sialyltransferase7; SIAT7; SIAT7B; SIATL1; ST6 (alpha N acetyl neuraminyl 2 3 beta galactosyl 1 3) N acetylgalactosaminide alpha 2 6 sialyltransferase 2; ST6GalNAc II; SIAT7-B; ST6GalNAcII; sialyltransferase-like 1; galNAc alpha-2,6-sialyltransferase II; (alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl galactosaminide B; sialyltransferase 7 ((alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl galactosaminide B; (alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl galactosaminide alpha-2,6-sialyltransferase; sialyltransferase 7 ((alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl galactosaminide alpha-2,6-sialyltransferase) B;
ST6GALNAC5
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5
ST6GALNAC5; ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5; sialyltransferase 7 ((alpha N acetylneuraminyl 2,3 beta galactosyl 1,3) N acetyl galactosaminide alpha 2,6 sialyltransferase) E , SIAT7E; alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5; MGC3184; ST6GalNAcV; Alpha N acetylgalactosaminide alpha 2,6 sialyltransferase 5; GalNAc alpha 2,6 sialyltransferase V; GD1 alpha synthase; Sialyltransferase 7E; SIAT7E; ST6GalNAc V; SIAT7-E; GalNAc alpha-2,6-sialyltransferase V; alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase V; ST6 neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5; alpha-N-acetylneuraminyl 2,3-betagalactosyl-1,3)-N-acetyl galactosaminide alpha-2,6-sialyltransferase E; sialyltransferase 7 (alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl galactosaminide alpha-2,6-sialyltransferase) E; sialyltransferase 7 ((alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl galactosaminide alpha-2,6-sialyltransferase) E;
ST6GALNAC6
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6
ST6GALNAC6; ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6; sialytransferase 7 ((alpha N acetylneuraminyl 2,3 betagalactosyl 1,3) N acetyl galactosaminide alpha 2,6 sialytransferase) F , SIAT7F; alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6; ST6GALNACVI; Alpha N acetylgalactosaminide alpha 2 6 sialyltransferase 6; CMP NeuAC:(beta) N acetylgalactosaminide (alpha)2 6 sialyltransferase member VI; GalNAc alpha 2 6 sialyltransferase VI; hST6GalNAc VI; RP11 203J24.3; Sialyltransferase 7F; Sialyltransferase7F; Sialytransferase 7 ((alpha N acetylneuraminyl 2 3 betagalactosyl 1 3) N acetyl galactosaminide alpha 2 6 sialytransferase) F; SIAT 7F; SIAT7F; ST6 (alpha N acetyl neuraminyl 2 3 beta galactosyl 1 3) N acetylgalactosaminide alpha 2 6 sialyltransferase 6; ST6GalNAc VI; SIAT7-F; galNAc alpha-2,6-sialyltransferase VI; CMP-NeuAC:(beta)-N-acetylgalactosaminide (alpha)2,6-sialyltransferase member VI; sialytransferase 7 ((alpha-N-acetylneuraminyl 2,3-betagalactosyl-1,3)-N-acetyl galactosaminide alpha-2,6-sialytransferase) F; RP11-203J24.3;
ST8SIA5
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5
ST8SIA5; ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5; sialyltransferase 8E (alpha 2, 8 polysialytransferase) , SIAT8E; alpha-2,8-sialyltransferase 8E; ST8Sia V; 8-sialyltransferase 8E; Alpha-2; SIA8E_HUMAN; Sialyltransferase 8E; Sialytransferase St8Sia V; SIAT8-E; SIAT8E; ST8SiaV; sialyltransferase 8E (alpha-2, 8-polysialytransferase);
ST6GALNAC1
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1
ST6GALNAC1; ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1; sialyltransferase 7 ((alpha N acetylneuraminyl 2,3 beta galactosyl 1,3) N acetyl galactosaminide alpha 2,6 sialyltransferase) A , SIAT7A; alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1; ST6GalNAcI; 6-sialyltransferase 1; 6-sialyltransferase I; Alpha N acetylgalactosaminide alpha 2 6 sialyltransferase 1; Alpha N acetylgalactosaminide alpha 2 6 sialyltransferase; Alpha-N-acetylgalactosaminide alpha-2; GalNAc alpha 2 6 sialyltransferase I; GalNAc alpha-2; HSY11339; SIA7A_HUMAN; Sialyltransferase 7A; SIAT7-A; SIAT7A; ST6 (alpha N acetyl neuraminyl 2 3 beta galactosyl 1 3) N acetylgalactosaminide alpha 2 6 sialyltransferase 1; ST6GalNAc I; STYI; galNAc alpha-2,6-sialyltransferase I; GalNAc alpha-2, 6-sialyltransferase I, long form; sialyltransferase 7 ((alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl galactosaminide alpha-2,6-sialyltransferase) A;
TAAR9
trace amine associated receptor 9 (gene/pseudogene)
TAAR9; trace amine associated receptor 9 (gene/pseudogene); trace amine associated receptor 9 , trace amine receptor 3 , TRAR3; trace amine-associated receptor 9; TA3; TAR3; trace amine receptor 3; trace amine receptor 9; TAR9; TRAR3;
TAAR4
trace amine-associated receptor 4
TAAR4; trace amine-associated receptor 4; Gm226; Ta2; TAAR 4; Trace amine associated receptor 4; taR-4; trace amine receptor 2; trace amine receptor 4;
TAAR7A
trace amine-associated receptor 7A
TAAR7A; trace amine-associated receptor 7A; Gm229; Trace amine associated receptor 7a; taR-7a;
TAAR7D
trace amine-associated receptor 7D
TAAR7D; trace amine-associated receptor 7D; Taar 7d; Trace amine associated receptor 7d; taR-7d;
B3GALNT2
beta-1,3-N-acetylgalactosaminyltransferase 2
B3GALNT2; beta-1,3-N-acetylgalactosaminyltransferase 2; UDP GalNAc:betaGlcNAc beta 1,3 galactosaminyltransferase, polypeptide 2; UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2; MGC39558; beta-1,3-GalNAc-T2; beta-1,3-galactosaminyltransferase 2; b;
ELFN2
extracellular leucine-rich repeat and fibronectin type III domain containing 2
ELFN2; extracellular leucine-rich repeat and fibronectin type III domain containing 2; extracellular leucine rich repeat and fibronectin type III containing 2 , extracellular leucine rich repeat and fibronectin type III domain containing 2 , leucine ric;
ST6GALNAC4
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 4
ST6GALNAC4; ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 4; sialyltransferase 7D ((alpha N acetylneuraminyl 2,3 beta galactosyl 1,3) N acetyl galactosaminide alpha 2,6 sialyltransferase) , SIA;
ENGASE
endo-beta-N-acetylglucosaminidase
ENGASE;endo-beta-N-acetylglucosaminidase;24622;ENSG00000167280;17q25.3;FLJ21865, DKFZp434P174;cytosolic endo-beta-N-acetylglucosaminidase;cytosolic endo-beta-N-acetylglucosaminidase;Di-N-acetylchitobiosyl beta-N-acetylglucosaminidase;Mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase;EC 3.2.1.96;
GALNT8
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 8 (GalNAc-T8) [ Ho
GALNT8;UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 8 (GalNAc-T8);4130;ENSG00000130035;GALNAC-T8;12p13.3;FLJ17364;probable polypeptide N-acetylgalactosaminyltransferase 8;probable polypeptide N-acetylgalactosaminyltransferase 8;pp-GaNTase 8;GalNAc transferase 8;polypeptide GalNAc transferase 8;protein-UDP acetylgalactosaminyltransferase 8;polypeptide N-acetylgalactosaminyltransferase 8;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 8;UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase 8;EC 2.4.1.41;
GALNTL6
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6 [ Homo sapi
GALNTL6;UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6;33844;ENSG00000174473;GALNT17;4q34.1;MGC44629;polypeptide N-acetylgalactosaminyltransferase-like 6;polypeptide N-acetylgalactosaminyltransferase-like 6;GaNTase 17;galNAc-T17;pp-GaNTase 17;GalNAc transferase 17;polypeptide GalNAc transferase 17;protein-UDP acetylgalactosaminyltransferase 17;putative polypeptide N-acetylgalactosaminyltransferase 17;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 17;UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 20;EC 2.4.1.41;
GCNT7
glucosaminyl (N-acetyl) transferase family member 7
GCNT7;glucosaminyl (N-acetyl) transferase family member 7;16099;ENSG00000124091;gcnt;C20orf105;dJ1153D9.2;20q13.2;beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 7;beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 7;beta 1,6-N-acetylglucosaminyltransferase;EC 2.4.1.-;
PLAC9
placenta-specific 9
PLAC9;placenta-specific 9;19255;ENSG00000189129;10q22.3;MGC104710;placenta-specific protein 9;placenta-specific protein 9;
PLAC1L
placenta-specific 1-like
PLAC1L;placenta-specific 1-like;26699;ENSG00000149507;TMEM122;11q12.1;FLJ36198;placenta-specific 1-like protein;placenta-specific 1-like protein;transmembrane protein 122;
WIZ
widely interspaced zinc finger motifs
WIZ;widely interspaced zinc finger motifs;30917;ENSG00000011451;ZNF803;19p13.1;protein Wiz;protein Wiz;WIZ zinc finger;zinc finger protein 803;widely-interspaced zinc finger motifs;widely-interspaced zinc finger-containing protein;
NAT10
N-acetyltransferase 10 (GCN5-related)
NAT10;N-acetyltransferase 10 (GCN5-related);29830;ENSG00000135372;ALP;NET43;11p13;FLJ10774, FLJ12179, FLJ23850, KIAA1709, DKFZp434C116;N-acetyltransferase 10;N-acetyltransferase 10;N-acetyltransferase-like protein;EC 2.3.1.-;
GALNT10
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 10 (GalNAc-T10) [
GALNT10;UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 10 (GalNAc-T10);19873;ENSG00000164574;GALNACT10;PPGALNACT10;PPGANTASE10;5q33.2;FLJ00205, FLJ11715, DKFZp586H0623;polypeptide N-acetylgalactosaminyltransferase 10;polypeptide N-acetylgalactosaminyltransferase 10;GalNAc transferase 10;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 10;EC 2.4.1.41;
B3GNTL1
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like 1
B3GNTL1;UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like 1;21727;ENSG00000175711;B3GNT8;17q25.3;MGC126253, MGC126256;UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1;UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1;BGnT-8;beta3Gn-T8;beta3GnTL1;beta-1,3-Gn-T8;BGnT-like protein 1;beta3Gn-T-like protein 1;beta-1,3-N-acetylglucosaminyltransferase 8;beta1,3-N-acetylglucosaminyltransferase-like protein 1;UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8;EC 2.4.1.-;
B4GALNT2
beta-1,4-N-acetyl-galactosaminyl transferase 2
B4GALNT2;beta-1,4-N-acetyl-galactosaminyl transferase 2;24136;ENSG00000167080;B4GALT;GALGT2;17q21.32;MGC142235, MGC142237;beta-1,4 N-acetylgalactosaminyltransferase 2;beta-1,4 N-acetylgalactosaminyltransferase 2;sda beta-1,4-GalNAc transferase;sd(a) beta-1,4-GalNAc transferase;beta-4-N-acetylgalactosaminyltransferase;UDP-GalNAc:Neu5Aca2-3Galb-R b1,4-N-acetylgalactosaminyltransferase;beta 1,4 N-acetylgalactosaminyltransferase/betal,4 GalNAcT/Sda-GalNAcT;UDP-GalNAc:Neu5Acalpha2-3Galbeta-R beta1,4-N-acetylgalactosaminyltransferase;EC 2.4.1.-;
NAT16
N-acetyltransferase 16 (GCN5-related, putative)
NAT16;N-acetyltransferase 16 (GCN5-related, putative);22030;ENSG00000167011;C7orf52;7q22.1;FLJ39237, DKFZp547K159;putative N-acetyltransferase 16;putative N-acetyltransferase 16;putative N-acetyltransferase C7orf52;
ECM2
extracellular matrix protein 2, female organ and adipocyte specific
ECM2;extracellular matrix protein 2, female organ and adipocyte specific;3154;ENSG00000106823;9q22.3;MGC126355, MGC126356;extracellular matrix protein 2;extracellular matrix protein 2;matrix glycoprotein SC1/ECM2;
GALNT7
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GalNAc-T7) [ Ho
GALNT7;UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GalNAc-T7);4129;ENSG00000109586;GalNAcT7;GALNAC-T7;4q31.1;N-acetylgalactosaminyltransferase 7;N-acetylgalactosaminyltransferase 7;pp-GaNTase 7;polypeptide GalNAc transferase 7;protein-UDP acetylgalactosaminyltransferase 7;polypeptide N-acetylgalactosaminyltransferase 7;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 7;EC 2.4.1.41;
Abo2
ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)
Abo2;
A130022J15Rik
EGF domain-specific O-linked N-acetylglucosamine (GlcNAc) transferase
Aer61; AI447490; AW214473; AW259391; A130022J15Rik;
2610002I17Rik
elongator acetyltransferase complex subunit 6
Tmem103; AV159994; 2610001P13Rik; 2610002I17Rik;
ELFN1
extracellular leucine-rich repeat and fibronectin type III domain containing 1
Ppp1r28; AI197272; A930017N06Rik;
MGAT5B
mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B
GnT-IX; mGnTVB; C330018B01; RP23-41E14.1;
ST6GALNAC3
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3
Siat7c;
Chst7
CHST7 carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 7 [ Homo sapiens ]
6 O sulfotransferase 5; C6ST 2; C6ST2; Carbohydrate sulfotransferase 7; Chondroitin 6 sulfotransferase 2; CHST 7; CHST7 carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 7; Galactose/N acetylglucosamine/N acetylglucosamine 6 O sulfotransferase 5; GlcNAc6ST 4; Gn6st-4; GST 5; N acetylglucosamine 6 O sulfotransferase 1;
Mgat2
mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase; GNT-II; glcNAc-T II; mannoside acetylglucosaminyltransferase 2; beta-1,2-N-acetylglucosaminyltransferase II; N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase II;
Ogt
O-linked N-acetylglucosamine (GlcNAc) transferase (UDP-N-acetylglucosamine:polypeptide-N-acetylglucosaminyl transferase)
B3gnt7
B3GNT7 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 [ Homo sapiens ]
3-Gn-T7; 3-N-acetylglucosaminyltransferase 7; B3GN7_HUMAN; B3gnt7; Beta 1 3 N acetylglucosaminyltransferase 7; Beta-1; Beta3Gn T7; Beta3Gn-T7; beta3GnT7; BGnT 7; BGnT-7; UDP GlcNAc betaGal beta 1 3 N acetylglucosaminyltransferase 7; UDP-GlcNAc:betaGal beta-1;
NAT
N-acetyltransferase
NAT; N-acetyltransferase; AANAT; Arylalkylamine N acetyltransferase; SNAT; ARD1A; ARD1 homolog A, N-acetyltransferase (S. cerevisiae); GNPNAT1; glucosamine-phosphate N-acetyltransferase 1; HGSNAT; heparan-alpha-glucosaminide N-acetyltransferase; MAK10; MAK10 homolog, amino-acid N-acetyltransferase subunit (S. cerevisiae); NAT1; N-acetyltransferase 1 (arylamine N-acetyltransferase); NAT2; N-acetyltransferase 2 (arylamine N-acetyltransferase); NAT5; N-acetyltransferase 5 (GCN5-related, putative); NAT6; N-acetyltransferase 6 (GCN5-related); NAT8; N-acetyltransferase 8 (GCN5-related, putative); NAT8L; N-acetyltransferase 8-like (GCN5-related, putative); NAT9; N-acetyltransferase 9 (GCN5-related, putative); NAT10; N-acetyltransferase 10 (GCN5-related); NAT11; N-acetyltransferase 11 (GCN5-related, putative); NAT12; N-acetyltransferase 12 (GCN5-related, putative); NAT13; N-acetyltransferase 13 (GCN5-related); NAT14; N-acetyltransferase 14 (GCN5-related, putative); NAT15; N-acetyltransferase 15 (GCN5-related, putative);
Biopharmaceutical Process and Product Related Impurities Analysis
During the drug development process, unknowns often arise from impurities and degradation products that can be formed during the manufacturing process or storage of the new drug. Current United States Food and Drug Administration (USFDA) regulatory guidance requires that studies be conducted to ide...
Pharmaceutical Stability Analysis
The stability of proteins is a critical factor in their manufacture, storage and use. Creative BioMart provides a complete range of ICH stability conditions and cGMP test methods to assure the accurate profile of your biopharmaceutical product during all stages of drug development, from early ...
Pharmaceutical Product Release Testing
The Product release testing is important for the quality control (QC) of pharmaceuticals. Release testing for biotechnology or biopharmaceutical products addresses the criteria of purity, concentration, consistency, identity and biosafety. Why Choosing Creative BioMart Pharmaceutical Product Testi...
Protein Acetylation Assay
As a leading biotechnology services supplier, Creative BioMart offers Histone acetylation assay and site identification services. With our expertise as a leader in the field of acetylation, Creative BioMart has created a set of new platform technologies. Creative BioMart has a convenient package of...
Biopharmaceutical Solution
Creative BioMart provides a broad range of biopharmaceutical solutions to assure the accurate profile of your biopharmaceutical product during all stages of drug development, from early research development to commercial or post approval studies. Our pharmaceutical solution utilizes expertise and k...
Surface Plasmon Resonance (SPR) Service
During the last decade, due to the ability to detect highly dynamic binding events, Surface Plasmon Resonance (SPR) has been intensively used in interaction studies involving life science research, drug discovery, electrochemical analysis, food quality and safety, environmental science, and chemical...
Intracellular Cytokine Detection and Activity Assay
Cytokines are a class of widely biologically active small molecule proteins which are synthesized and secreted upon stimulation by immune cells (such as monocytes, macrophages, T cells, B cells, NK cells, etc.) and certain non-immune cells (endothelial cells, epidermal cells, fibroblasts, etc.). Cyt...
Cell: A Promising Trend That Avoids Foreign Rejection and Replaces Damaged Neurons on self
This is a confocal micrograph of a primary human fibroblast cell grown in culture stained blue for actin, a highly abundant protein that makes up the cytoskeleton of cells. Mitochondria are shown in green. According to some statistics, it is estimated that 25% Americans will suffer from a neurode...
Scientists Reveal the Detailed Structure of Protein C4BP for Pharmaceutical Transport
Protein C4BP, the complement component 4 binding protein, is a part of our innate immune system which serves as the first countermeasures against invading pathogens. It could defend against bacterial in the blood. But in order to find reveal how exactly the protein acts on other molecules, sci...
In Face of Pancreatic Cancer
Gene Database Associated with Pancreatic Cancer for Your Reference Whenever talk about pancreatic cancer, people would feel scared. In China, pancreatic cancer is called as the king of all cancers due to its poor prognosis and short survival time. In developed countries, it is also a very trouble...
New Hormone Target Clues for Biopharmaceutical Companies
A new research found the effective effect of obesity-against of two hormones in gut, which might be an exciting news for drug companies and individuals who want to keep slim. The two hormones are PYY3-36 and PP. PYY3-36, or Peptide YY(peptide tyrosine tyrosineorpancreatic peptide YY3-36, PYY), is...
Scientists Uncover the Crystal Structures of Class B GPCRs and Expand Their Pharmaceutical Importance
GPCRs, a kind of membrane receptors, serve as extracellular signal sensors, including photons, ions, small organic molecules, even the whole proteins. About one third of known drugs use GPCRs to be active targets. Currently, all the published GPCR structures come from class A. But recently the crys...
Scientists Found New Role of Deacetylase SIRT1
In previous studies, deacetylase SIRT1 has been identified the ability to repair damaged DNA. In addition to this, scientists recently found a new ability of SIRT1help to stable the genomes of experimental mice with neurodegenerative diseases, for example, Alzheimer's disease and amyotrophic later...
A Summary of Characteristics of the Bio-pharmaceutical Industry
Bill Gates once predicted that the next richest man in the world replacing him will come from genetic area. With the advancement of modern biotechnology, bio-pharmaceutical industry is getting more and more achievements. Here, Id like to sum the characteristics of the bio-pharmaceutical industry cou...
EU Regulatory: Giant Pharmaceuticals Are Fined Again for Disorganizing Market
On last Tuesday, EU regulators announced another pecuniary penalty event on pharmaceutical giant Johnson Johnson and Novartis because they tried to stop the selling launch of a cheaper painkiller biosimilar. They have to accept a fine of 16.3 million (i.e. $ 22 million); meanwhile European Commissi...
Drug Company Concern: Trend in Pharmaceutical Information
On January 3rd, the Public Accounts Committee, British House of Commons published a report with regard to the reservation issue of Tamiflu (a kind of influenza drug that is usually used in the treatment of both seasonal flu and swine flu), which sparked a discussion about...
Big Shuffle in Pharmaceutical Industry: New Round of GMP Certification Creates Chance for Company Acquisition
According to China Food and Drug Administration (CFDA) report, as of December 31, 2013, more than seven hundreds of enterprises in sterile pharmaceutical manufacture in China have approved the newly revised GMP certification, however, more than four ...
Discussion: Will Google Invest Bio-pharmaceuticals after Its Health-care Part
Google once said it wanted to declare war against disease. When it said so, 23andMe, invested by it has serviced 200,000 people; iPierian (mainly for stem cells), invested by it was facing a big moment. Thus we dont need to feel surprised when we hear about that Google is going to set up a new compa...
Cleveland Clinic Published Its Selection of Top Three “Groundbreaking” Pharmaceutics
As usual, Cleveland Clinic will pick out some groundbreaking pharmaceutics that may make big difference for healthcare industry in their late development stages. This year who will be picked by Cleveland? According to internal news, Gilead's sofosbuvir, Novartis heart drugs serelaxin as well as Phar...
An Interesting Phenomenon for the Input and Output of Pharmaceutical Industry
Unlike pharmaceutical industry, many industries will have smooth progress during developing process. However, pharmaceutical industry may suffer from huge frustration even failure in their RD process. It is estimated that the overall failure rate of developing of a new drug could reach 95%, and the...
The Brief Inventory of Fines Multinational Pharmaceutical Companies Paid
Following manipulating articles in Journals, GlaxoSmithKline (GSK) entered another trouble time in China. The Public Security Department have begun to investigate its suspicion of commercial bribery, according to Beijing News report, as of July 14, at least four travel ag...
Who will be the Final Bidder for Onyx Pharmaceuticals Inc.?
The first-round bid for Onyx Pharmaceuticals Inc. will begin this week, as told by someone familiar with the matter. From June 30, Onyx enlisted Centerview Partners to help find bidders. ...
Company Acquire: In Face with So Many Suitors, Bausch & Lomb Will Belong to Whom?
According to Bloomberg, the private drug and device company Bausch Lomb Company, which is owned by private equity Warburg Pincus, recently was fiercely chased by many giants, such as by Abbott Laboratories (ABT), Johnson Johnson (JNJ), Sanofi and others. Warbur...
MedImmune Works with NGM Biopharmaceuticals to Develop EEC-related Therapeutics
On June 17, 2013, AstraZeneca announced that its global biologics research and development branchMedImmuneand and NGM Biopharmaceuticals, Inc. entered into an exclusive agreement to discover, develop and commercialize novel therapeutics from NGMs enteroendocrine cell (EEC) programme. The main focus ...
What Biopharmaceutical Innovations and New Drug Discovery Bring?
There is no exact definition for innovation. While there at least should be a substantial improvement and not a small change over what is currently available, for example, the growth and maturation of high throughput screening and microarray technique. The Biopharmaceutical and drug discovery...
Principle and Protocol of Surface Plasmon Resonance (SPR)
Surface plasmon resonance (SPR) is one of the commonly used technologies for detailed and quantitative studies of protein-protein interactions and determination of their equilibrium and kinetic parameters. SPR provides excellent instrumentation for a label-free, real-time investigation of protein-pr...
